Page last updated: 2024-12-10

sodium dodecyl sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Sodium Dodecyl Sulfate: An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

sodium dodecyl sulfate : An organic sodium salt that is the sodium salt of dodecyl hydrogen sulfate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3423265
CHEMBL ID23393
CHEBI ID8984
SCHEMBL ID1102
MeSH IDM0020097

Synonyms (164)

Synonym
S-4601
dehydrag sulfate gl emulsion
dodecyl sulfate sodium
perklankrol esd 60
natriumlaurylsulfat
jordanol sl-300
sodium monododecyl sulfate
caswell no. 779
epa pesticide chemical code 079011
cp 75424
finasol osr2
laurylsiran sodny [czech]
natrium laurylsulfuricum
lauryl sulfate, sodium salt
ccris 6272
finasol osr(sub 2)
dehydag sulphate gl emulsion
monagen y 100
einecs 205-788-1
hsdb 1315
ai3-00356
nsc 402488
incronol sls
sodium lauryl sulfate, dental grade
sodium lauryl sulfate 30%
sodium dodecylsulfate
sodium dodecyl sulphate
CHEBI:8984 ,
sodium lauryl sulphate
duponal
nsc-402488
stepanol t 28
sodiumlauryl ether sulfate
stepanol waq
sodium lauryl sulfate ether
avirol 118 conc
sodium n-dodecyl sulfate
standapol wa-ac
dupanol waq
duponol qc
duponol wa dry
stepanol wa-100
dodecyl sulfate, sodium salt
stepanol wa
maprobix neu
stepanol methyl
nci-c50191
sterling waq-ch
dehydag sulfate gl emulsion
lauyl sodium sulfate
lauryl sulfate sodium salt
stepanol wa paste
standapol waq
nals
stepanol me dry aw
texapon k 1296
stepanol methyl dry aw
sulfuric acid monododecyl ester sodium salt
stepanol me dry
anticerumen
perlankrol l
stepanol wac
duponol waqe
standapol waq special
standapol 112 conc
standapol was 100
NCGC00091020-01
NCGC00091020-02
sodium dodecyl sulfate
sodium lauryl sulfate
151-21-3
DB00815
sodium laurilsulfate
D01045
sodium lauryl sulfate (jp17/nf)
NCGC00091020-03
sodium dedecyl sulfate
S-4600 ,
S0588
laurylsulfuric acid sodium salt
dodecylsulfuric acid sodium salt
CHEMBL23393
sodium lauryl sulfate, synthetic
e487
texapon k 12 p
ipc-sds
D1403
I0352
368gb5141j ,
sodium lauryl sulfate [jan:nf]
laurylsiran sodny
sulfuric acid monododecyl ester sodium salt (1:1)
ec 205-788-1
unii-368gb5141j
NCGC00259163-01
tox21_201614
tox21_300149
NCGC00254225-01
tox21_111059
dtxsid1026031 ,
dtxcid906031
cas-151-21-3
lauryl sulfate sodium
rhodapon ub
dodecyl sulfate sodium salt
FT-0603358
sodium lauryl sulfate [ii]
sodium lauryl sulfate [mi]
sodium laurilsulfate [ep impurity]
sodium lauryl sulfate [jan]
sodium lauryl sulfate [fcc]
sodium laurilsulfate [mart.]
sodium lauryl sulfate [hsdb]
sodium lauryl sulfate [usp-rs]
sodium lauryl sulfate [who-dd]
sodium laurilsulfate [ep monograph]
sodium lauryl sulfate [inci]
sodium lauryl sulfate [vandf]
sodium monododecyl sulphate
AKOS015897278
SCHEMBL1102
NCGC00274082-01
tox21_111059_1
sodium lauryl sulfate nf
DBMJMQXJHONAFJ-UHFFFAOYSA-M
sodiumlauryl sulfate
sodium dodecylsulphate
empicol
AKOS025147308
dodecyl sulfuric acid ester sodium salt
CS-B1770
sodium n-dodecyl sulfate, 98%, for electrophoresis
mfcd00036175
sodiumdodecylsulfate
F0001-0539
1334-67-4
12738-53-3
12765-21-8
sodium;dodecyl sulfate
FT-0700721
Q422241
dodecyl sodium sulfate, dodecyl sulfate sodium salt, lauryl sulfate sodium salt, sds, sodium lauryl sulfate
F16341
AS-14730
EN300-103513
sodium n-dodecyl sulphate
dodecyl sulfuric acid sodium salt
dodecyl sulphate sodium salt
sodium dodecyl sulphate (sds)
sodium dodecyl sulfate biotech grd 100g
dodecyl sulphuric acid sodium salt
lauryl sulphate sodium salt
sodium-dodecyl-s-sds
sodium dodecyl sulfate (sds)
BCP30594
sodium dodecylsulfate;sodium lauryl sulphate;dodecyl sodium sulfate
sodium lauryl sulfate, sds
sds (20% solution)
bdbm50530482
CS-0182093
HY-Y0316
HY-Y0316B
sodium dodecyl sulfate for electrophoresis, inverted exclamation marky98.5%
Z1365432828

Research Excerpts

Overview

Sodium dodecyl sulfate (SDS) removal is a vital procedure in SDS-assisted bottom-up proteomics. SDS affects the quality of the data in electrospray ionization mass spectrometry (ESI-MS) SDS impedes MS detection and therefore must be removed prior to analysis.

ExcerptReferenceRelevance
"Sodium dodecyl sulfate is a surfactant that may control this aggregation."( Antimicrobial photodynamic therapy mediated by methylene blue in surfactant vehicle as adjuvant to periodontal treatment. Randomized, controlled, double-blind clinical trial.
Damante, CA; Deana, A; Kassa, CT; Kato, IT; Pavani, C; Prates, RA; Rost-Lima, KS; Salviatto, LTC; Tortamano, ACAC; Wainwright, M, 2023
)
1.63
"Sodium dodecyl sulfate (SDS) is a well-known protein denaturing agent. "( Susceptibility of Cu(I) transport ATPases to sodium dodecyl sulfate. Relevance of the composition of the micellar phase.
González-Flecha, FL; Incicco, JJ; Melian, NA; Recoulat Angelini, AA, 2023
)
2.61
"Sodium dodecyl sulfate (SDS) removal is a vital procedure in SDS-assisted bottom-up proteomics because SDS affects the quality of the data in electrospray ionization mass spectrometry (ESI-MS). "( Sodium dodecyl sulfate removal during electrospray ionization using cyclodextrins as simple sample solution additive for improved mass spectrometric detection of peptides.
Quirino, JP, 2018
)
3.37
"Sodium dodecyl sulfate (SDS) is a detergent used as a strong denaturant of proteins in gel electrophoresis. "( Sarkosyl: A milder detergent than SDS for identifying proteins with moderately high hyperstability using gel electrophoresis.
Colón, W; Hill, S; Martin, A; Ortiz-Perez, B; Patrick, J; Thibeault, J; Xia, K; Zhang, S, 2019
)
1.96
"Sodium dodecyl sulfate is a detergent that disrupts cell membranes, activates cell wall integrity signaling and restricts cell growth in Saccharomyces cerevisiae. "( Tryptophan confers resistance to SDS-associated cell membrane stress in Saccharomyces cerevisiae.
Ikui, AE; Schroeder, L, 2019
)
1.96
"Sodium dodecyl sulfate (SDS) is a widely used anionic surfactant in industry and research settings, and is known to have a detrimental effect to the environment. "( Structural and functional analysis show that the Escherichia coli uncharacterized protein YjcS is likely an alkylsulfatase.
Dong, Y; Gao, Z; Liang, Y; Liu, Q, 2014
)
1.85
"Sodium dodecyl sulfate is a favored denaturant in proteomic workflows, facilitating cell lysis and protein dissolution; however, SDS impedes MS detection and therefore must be removed prior to analysis."( Automated SDS Depletion for Mass Spectrometry of Intact Membrane Proteins though Transmembrane Electrophoresis.
Doucette, AA; Faulkner, M; Kachuk, C; Liu, F, 2016
)
1.16
"Sodium dodecyl sulfate (SDS) is a highly effective and widely used protein denaturant. "( Refolding SDS-denatured proteins by the addition of amphipathic cosolvents.
Michaux, C; Pomroy, NC; Privé, GG, 2008
)
1.79
"Sodium dodecyl sulfate (SDS) is a strong surfactant that is widely used in protein sample preparation. "( Ammonium dodecyl sulfate as an alternative to sodium dodecyl sulfate for protein sample preparation with improved performance in MALDI mass spectrometry.
Li, L; Zhang, N, 2002
)
2.02
"The sodium dodecyl sulfate binding acts as a shield which limits charge-charge interaction in the basic protein molecule thus preventing aggregate formation while TBR imposes no such restraints."( The solution behavior of the bovine myelin basic protein in the presence of anionic ligands. Binding behavior with the red component of trypan blue and sodium dodecyl sulfate.
Liebes, LF; Phillips, WD; Zand, R, 1976
)
0.94

Effects

Sodium dodecyl sulfate (SDS) has a wide range of applications in the chemical industry due to its excellent characteristics. SDS has a net stabilizing effect up to a molar ratio of 10:1 (ligand to protein)

Sodium dodecyl sulfate has a net stabilizing effect up to a molar ratio of 10:1 (ligand to protein) SDS has consistently been shown to induce secondary structure, particularly alpha-helices, in polypeptides.

ExcerptReferenceRelevance
"Sodium dodecyl sulfate (SDS) has a wide range of applications in the chemical industry due to its excellent characteristics including good emulsification, foaming, water solubility and stability, easy synthesis and low price. "( A cationic fluorescent probe for highly selective detection of sodium dodecyl sulfate (SDS) by electrostatic and hydrophobic self-assembly.
Chen, H; Li, J; Mu, X; Qin, Y; Yan, L, 2021
)
2.3
"Sodium dodecyl sulfate has a net stabilizing effect up to a molar ratio of 10:1 (ligand to protein)."( DSC studies on bovine serum albumin denaturation. Effects of ionic strength and SDS concentration.
Barone, G; De Sena, C; Fessas, D; Giancola, C; Graziano, G, 1997
)
1.02
"Sodium dodecyl sulfate (SDS) has a wide range of applications in the chemical industry due to its excellent characteristics including good emulsification, foaming, water solubility and stability, easy synthesis and low price. "( A cationic fluorescent probe for highly selective detection of sodium dodecyl sulfate (SDS) by electrostatic and hydrophobic self-assembly.
Chen, H; Li, J; Mu, X; Qin, Y; Yan, L, 2021
)
2.3
"Sodium dodecyl sulfate has a net stabilizing effect up to a molar ratio of 10:1 (ligand to protein)."( DSC studies on bovine serum albumin denaturation. Effects of ionic strength and SDS concentration.
Barone, G; De Sena, C; Fessas, D; Giancola, C; Graziano, G, 1997
)
1.02
"Sodium dodecyl sulfate (SDS) has consistently been shown to induce secondary structure, particularly alpha-helices, in polypeptides, and is commonly used to model membrane and other hydrophobic environments. "( Involvement of electrostatic interactions in the mechanism of peptide folding induced by sodium dodecyl sulfate binding.
Böckmann, A; Geourjon, C; McLeish, MJ; Montserret, R; Penin, F, 2000
)
1.97
"Sodium dodecyl sulfate (SDS) has been used to induce a dry scaly skin condition in human subjects. "( Stratum corneum lipid abnormalities in surfactant-induced dry scaly skin.
Fulmer, AW; Kramer, GJ, 1986
)
1.71

Treatment

Sodium dodecyl sulfate (SDS) pretreatment and 2-stage curing process have shown effective to solve these problems, respectively. Treatment with SDS converted IHD-J into particles of two types.

ExcerptReferenceRelevance
"Sodium dodecyl sulfate (SDS) pretreatment and 2-stage curing process have shown effective to solve these problems, respectively."( Use of sodium dodecyl sulfate pretreatment and 2-stage curing for improved quality of salted duck eggs.
Deng, Y; Lian, Z; Qian, B; Qiao, L; Yue, J; Zhao, Y; Zhu, G, 2014
)
1.58
"Sodium dodecyl sulfate treatment of otoconia increased the Ca2+ uptake."( In vitro calcium ion turnover in otoconia of the guinea pig.
Takumida, M; Yajin, K; Zhang, DM, 1997
)
1.02
"Sodium dodecyl sulfate treatment, which partially activates the latent form of natural PAI-1, inactivated rPAI-1."( Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
Davis, GL; Duke, JL; Kingsley, D; Pierce, SK; Reilly, TM; Seetharam, R; Sisk, WP; Walton, HL, 1990
)
1
"Sodium dodecyl sulfate treatment of CA9 that had not been reacted with Pronase did not inactivate virus or cause viral RNA release."( Degradation of coxsackievirus type A9 by proteolytic enzymes.
Cliver, DO; Herrmann, JE, 1973
)
0.97
"Treatment with sodium dodecyl sulfate (SDS) converted the vaccinia virus strain IHD-J into particles of two types: (i) ghosts which possessed a thin-membrane vesicle derived from basement part of the virus membrane with attached lateral bodies and a membranous structure derived from the core wall and (ii) aggregates of a DNA-nucleoprotein eluted from the core. "( Location of DNA-binding proteins and disulfide-linked proteins in vaccinia virus structural elements.
Ichihashi, Y; Oie, M; Tsuruhara, T, 1984
)
0.62

Toxicity

Sodium dodecyl sulfate (SDS) was used as a toxic anionic surfactant. Glutamic acid-based cationic bicatanar surfactants were used as less toxic. The study investigated the toxic effects of the insecticides lindane and chlorpyrifos.

ExcerptReferenceRelevance
" A broad spectrum of model toxic compounds was evaluated for toxicity on mouse skin JB6 cells in culture."( Studies of skin toxicity in vitro: dose-response studies on JB6 cells.
Berezesky, IK; Fitzpatrick, MJ; Jain, PT; Phelps, PC; Trump, BF, 1992
)
0.28
" The single dose LD50 values for a non-carbopol-containing CP (Gly-Oxide) and a carbopol-containing CP (Proxigel) in mice were found to be 143."( Toxicity of two carbamide peroxide products used in nightguard vital bleaching.
Haywood, VB; Heymann, HO; Woolverton, CJ, 1993
)
0.29
" These compounds are widely used by industries, causing toxic effects to ecosystems and particularly having an impact on human health."( Toxicity of potential irritants in mammalian cells in vitro.
López, A; Pozuelo, JM; Santa María, A; Sanz, F, 1996
)
0.29
"This investigation was undertaken to determine prolonged adverse effects of benzalkonium chloride (BzCl), a cationic surfactant, and sodium dodecyl sulfate (SDS), an anionic surfactant, after an initial treatment of and subsequent removal from a primary culture system of rabbit corneal epithelial cells."( Prolonged adverse effects of benzalkonium chloride and sodium dodecyl sulfate in a primary culture system of rabbit corneal epithelial cells.
Acosta, D; Grant, RL, 1996
)
0.75
" The organic solvents ethanol, DMSO, and polyethylene glycol 400 were not toxic in either test in concentrations of 1-2%."( Evaluation of toxicity of medical devices using Spirotox and Microtox tests: I. Toxicity of selected toxicants in various diluents.
Nałecz-Jawecki, G; Rudź, B; Sawicki, J, 1997
)
0.3
" The method is rapid, precise, and lacks any toxic byproduct."( In vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium laurylsulfate cytotoxicity.
Coiffard, C; Coiffard, LJ; De Roeck-Holtzhauer, Y; Rivalland, P; Verhulst, C, 1998
)
0.3
" Variable release of tumor necrosis factor-alpha and interleukin-8 from keratinocytes occurred only at toxic threshold concentrations of the phenols or sodium dodecyl sulfate."( Cytokine release and cytotoxicity in human keratinocytes and fibroblasts induced by phenols and sodium dodecyl sulfate.
Barr, RM; Greaves, MW; Mallet, AI; Newby, CS, 2000
)
0.72
"In the framework of a German-Romanian scientific cooperation, experiments were performed to evaluate feasible and cheap techniques for the safe storage of mine waste to prevent acid rock drainage (ARD)."( Large-scale experiments for microbiological evaluation of measures for safeguarding sulfidic mine waste.
Jelea, M; Jozsa, PG; Kovacs, ZM; Sand, W; Schippers, A, 2001
)
0.31
" At this concentration, SDS was almost six times more toxic than ABS (LT50 is compared)."( Comparative study of the acute toxicity of anionic surfactans alkyl benzene sulphonate (ABS) and sodium dodecyl sulphate (SDS) on gilthead, Sparus aurata L., eggs.
Carrasco, C; Ordoñez, FJ; Ribelles, A; Rosety, I; Rosety, JM; Rosety, M; Rosety-Rodríguez, M, 2001
)
0.31
"We report the conformational and toxic properties of two novel fibril-forming prion amyloid sequences, GAVVGGLG (PrP(119-126)) and VVGGLGG (PrP(121-127))."( Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
Jayakumar, R; Murali, J; Satheeshkumar, KS, 2004
)
0.32
" On the basis of toxicity tests to aquatic organisms all tested anionic surfactants were harmful (LC50 between 10 and 100 mg l(-1)), whereas nonionic ones were toxic (LC50 between 1 and 10 mg l(-1)) or even highly toxic (LC50 below 1 mg l(-1))."( Acute toxicity and genotoxicity of five selected anionic and nonionic surfactants.
Kalka, J; Liwarska-Bizukojc, E; Malachowska-Jutsz, A; Miksch, K, 2005
)
0.33
"This study presents the toxic effects of a very known and used compound in pharmaceutical products and from cosmetic market, a detergent (surface-active) anionic."( [Skin toxicity of sodium lauryl sulfate as evidenced in an animal model].
Dehelean, C; Dinte, E; Dragomirescu, A; Hegheş, A; Năstase, V,
)
0.13
"This study investigated the toxic effects of the insecticides lindane and chlorpyrifos, the herbicide diuron, the organometallic antifoulant tributyltin (TBT), and the surfactant sodium dodecyl sulfate (SDS) on the early life stages of Paracentrotus lividus (Echinodermata, Euechinoidea), Ciona intestinalis (Chordata, Ascidiacea), Maja squinado and Palaemon serratus (Arthropoda, Crustacea) in laboratory acute toxicity tests."( Toxicity of organic compounds to marine invertebrate embryos and larvae: a comparison between the sea urchin embryogenesis bioassay and alternative test species.
Beiras, R; Bellas, J; Fernández, N; Mariño-Balsa, JC, 2005
)
0.52
"The purpose of this article is to discuss possible adverse effects and emergency treatments following the ingestion of chlorhexidine (CHX)."( Systemic toxicity following ingestion of the chlorhexidine gluconate solution: a case report.
Ghalayani, P; Kolahi, J; Varshosaz, J, 2006
)
0.33
" Of the evaluating methods, Toxic Unit is most sensitive with higher value of its parameter."( [Joint toxicity on multi-component mixtures of SDS and substituted aromatic compounds].
Dong, YY; Lei, BL; Zhang, CB; Zhang, FJ, 2006
)
0.33
" It is suggested that the gel formulation containing sodium lauryl sulfate is safe for most tissues that could be exposed to the product under normal use."( Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models.
Bergeron, MG; Bussières, M; Laforest, G; Piret, J, 2008
)
0.35
"No serious adverse events (AEs) were reported."( Safety, tolerance and acceptability of the Invisible Condom and its vaginal applicator in healthy women and their male sexual partners.
Bergeron, MG; Désormeaux, A; Drouin, J; Gagnon, MT; Guilbert, E; Mâsse, B; Omar, RF; Trottier, S; Vezina, F, 2007
)
0.34
"The aim of this study was to investigate high-molecular-weight hyaluronan (HA-HMW) corneal protection against sodium lauryl sulfate (SLS)-induced toxic effects with in vitro and in vivo experimental approaches."( Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects.
Chavinier, E; Dutot, M; Liang, H; Pauloin, T; Rat, P; Warnet, JM, 2009
)
0.35
"A good correlation was seen between in vitro and in vivo findings showing that HA-HMW decreases SLS-induced toxic effects and protects cornea."( Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects.
Chavinier, E; Dutot, M; Liang, H; Pauloin, T; Rat, P; Warnet, JM, 2009
)
0.35
" No study product-related serious adverse events were reported."( A randomized, double-blind, placebo-controlled safety and acceptability study of two Invisible Condom formulations in women from Cameroon.
Bergeron, MG; Domingo, MC; Fokoua, S; Giguere, JF; Mâsse, B; Mbopi-Keou, FX; Mbu, ER; Mwatha, A; Nkele, NN; Omar, RF; Piret, J; Trottier, S; Tsague, L; Zekeng, L, 2009
)
0.35
" Sodium and ammonium laureth sulfate have not evoked adverse responses in any toxicological testing."( Final report of the amended safety assessment of sodium laureth sulfate and related salts of sulfated ethoxylated alcohols.
Alan Andersen, F; Belsito, DV; Bergfeld, WF; Hill, RA; Klaassen, CD; Marks, JG; Robinson, VC; Shank, RC; Slaga, TJ; Snyder, PW, 2010
)
0.36
" We firstly established the illumination conditions that do not affect mitochondrial structure and calculated the maximum safe light dose to which the cells can be exposed."( Autofluorescence microscopy: a non-destructive tool to monitor mitochondrial toxicity.
Macko, P; Palosaari, T; Rodrigues, RM; Whelan, MP, 2011
)
0.37
" A phenomenological double logistic model was proposed to quantify and relate the observed kinetic changes of fluorescence to the toxic potency of chemical compounds."( Non-invasive monitoring of cytotoxicity based on kinetic changes of cellular autofluorescence.
Bednarkiewicz, A; Rodrigues, RM; Whelan, MP, 2011
)
0.37
" Sodium lauryl ether sulfate and polyoxyethylene lauryl ether significantly damaged the membrane, disturbed cellular metabolic activity, and decreased mitochondrial activity and the protein synthesis rate; however, their toxicity was far below those of the severely toxic chemicals at comparable concentrations."( Cellular toxicity of surfactants used as herbicide additives.
Gil, HW; Hong, SY; Kim, YH; Lee, EY; Seok, SJ; Song, HY; Yang, JO, 2012
)
0.38
" The shorter chain length surfactant (C(6)) was shown to be less cytotoxic than sodium dodecyl sulfate (SDS), and all the lysine-derived surfactants were less toxic than the cationic cetyl trimethylammonium bromide (CTAB)."( In vitro cytotoxicity of a thermoresponsive gel system combining ethyl(hydroxyethyl) cellulose and lysine-based surfactants.
Araújo, MJ; Calejo, MT; Cardoso, AM; de Lima, MC; Jurado, AS; Kjøniksen, AL; Marques, EF; Nyström, B; Sande, SA, 2013
)
0.62
" In this study, sodium dodecyl sulfate (SDS) was used as a toxic anionic surfactant, and glutamic acid-based cationic bicatanar surfactant (GS) was used as less toxic cationic amino acid-based surfactant."( Genotoxicity potentials of anionic and cationic amino acid-based surfactants.
Cosgun, S; Kekeç, G, 2015
)
0.76
" A cytotoxicity assay is the first and most essential test to evaluate biocompatibility of various toxic substances."( Label-free and quantitative evaluation of cytotoxicity based on surface nanostructure and biophysical property of cells utilizing AFM.
Cheong, Y; Kang, SW; Lee, GJ; Lee, YJ; Park, HK, 2013
)
0.39
"Skin irritation is one of the most common adverse reactions in hydroquinone (HQ) and retinoic acid (RA)."( S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
Cheong, KA; Kim, CH; Lee, AY; Noh, M, 2014
)
0.4
"Vinyl polysiloxane (VPS) is elastomeric dental impression material which, despite having very few reports of adverse reactions, has shown high levels of cytotoxicity that is difficult to be interpreted without referencing to the positive control material."( Positive control for cytotoxicity evaluation of dental vinyl polysiloxane impression materials using sodium lauryl sulfate.
Kim, KM; Kim, KN; Kwon, JS; Lee, SB, 2014
)
0.4
" AT3 variants carrying the expanded polyQ are prone to associate with each other into amyloid toxic aggregates, which are responsible for neuronal death with ensuing neurodegeneration."( The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model.
Bonanomi, M; Invernizzi, G; Regonesi, ME; Tortora, P; Visentin, C, 2015
)
0.42
" The goal of this study was to validate spheroid contraction as a cytotoxic endpoint using 3T3 fibroblasts in response to 5 toxic compounds (all-trans retinoic acid, dexamethasone, doxorubicin, 5'-fluorouracil, forskolin), sodium dodecyl sulfate (+control), and penicillin-G (-control)."( A spheroid toxicity assay using magnetic 3D bioprinting and real-time mobile device-based imaging.
Becker, JL; Chen, J; Desai, PK; Gage, JA; Haisler, WL; Hebel, C; Liao, A; Neeley, SK; Raphael, RM; Shen, T; Shiao, S; Souza, GR; Tseng, H, 2015
)
0.6
" Cytotoxicity of ANF hydrosol was examined to get an idea of the toxic level of this hydrosol toward cultured normal human cells."( Aggregation induced emission from α-napthoflavone microstructures and its cyto-toxicity.
Chattopadhyay, D; Das, D; Maity, A; Mazumdar, P; Misra, A; Roy, S; Tripathy, S, 2016
)
0.43
"Possible harmful effects of SLS were reported as mucosal desquamation, irritation or inflammation of oral mucosa or the dorsal part of the tongue, ulcerations, and toxic reactions in the oral cavity."( Side effects of sodium lauryl sulfate applied in toothpastes: A scoping review.
Feilzer, AJ; Kasi, SR; Özcan, M, 2022
)
0.72

Pharmacokinetics

ExcerptReferenceRelevance
"The pharmacokinetic profiles of two iodinated human epidermal growth factors (125I-hEGF51 and 125I-hEGF53) in rats receiving a single intravenous dose have been investigated using three independent bioanalytical techniques."( Pharmacokinetic evaluation of two human epidermal growth factors (hEGF51 and hEGF53) in rats.
Chang, J; Elsea, SH; Hwang, KK; Kuo, BS; Kusmik, WF; Poole, JC,
)
0.13
" The pharmacokinetic study of the two lacidipine tablets was carried out in the healthy beagle dogs at a single dose of 4 mg."( Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation.
He, S; He, Z; Liu, X; Sun, J; Sun, M; Sun, Y; Wang, Y, 2012
)
0.38
" The pharmacokinetic studies demonstrated improved pharmacokinetic parameters for the formulation containing SLS and HPC."( Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation.
Bilatto, SE; Cabral, LM; Corrêa, DS; da Costa, MA; Fandaruff, C; Hoffmeister, CR; Pitta, LR; Prado, LD; Rocha, HV; Silva, MA; Tasso, L, 2017
)
0.46
"The study successfully identified a Phase III formulation with a reduced SLS content, which when administered following a low-fat meal, gave comparable pharmacokinetic exposure to the Phase I/II formulation administered under the same conditions."( Application of a Novel 'Make and Test in Parallel' Strategy to Investigate the Effect of Formulation on the Pharmacokinetics of GDC-0810 in Healthy Subjects.
Cheeti, S; Chen, B; Gates, M; Girish, S; Hou, HH; Liu, L; Morley, R; Musib, L; Nelson, E; Sahasranaman, S; Walker, H, 2018
)
0.48
" When the oral formulation is exposed to different pH ranges in the gastrointestinal (GI) tract, drug precipitation, or incomplete dissolution may occur resulting in decreased drug absorption and higher intra- and inter-patient pharmacokinetic (PK) variabilities."( Development of an enhanced formulation to minimize pharmacokinetic variabilities of a weakly basic drug compound.
Gaebele, T; Menger, R; Pu, YE; Tong, Z, 2022
)
0.72

Compound-Compound Interactions

Sodium acid sulfate and levulinic acid (LA) in combination with sodium dodecyl sulfate (SDS) was effective in inactivating human pathogens on Romaine lettuce.

ExcerptReferenceRelevance
" Replacement of EGTA by Ca2+ in the gel, combined with the blotting of electrophoretically separated proteins on polyvinylidene difluoride membranes and subsequent 45Ca2+ overlay, proved a very effective means of detecting Ca(2+)-binding proteins."( Detection of Ca(2+)-binding proteins by electrophoretic migration in the presence of Ca2+ combined with 45Ca2+ overlay of protein blots.
Champeil, P; Deschamps, S; Garrigos, M; le Maire, M; Lund, S; Møller, JV; Viel, A, 1991
)
0.28
"An assessment study was carried out to evaluate the performance of the low-angle laser light-scattering technique combined with high-performance porous silica gel chromatography in the presence of sodium dodecyl sulfate and precision differential refractometry."( Estimation of molecular weights of membrane proteins in the presence of SDS by low-angle laser light scattering combined with high-performance porous silica gel chromatography. Confirmation of the trimer structure of porin of the E. coli outer membrane.
Kameyama, K; Nakae, T; Takagi, T, 1982
)
0.45
" In this study we used H/DX MS combined with docking simulation to localize the interaction sites of a tested ligand, sodium dodecyl sulfate (SDS), binding to BLG."( Elucidation of the binding sites of sodium dodecyl sulfate to β-lactoglobulin using hydrogen/deuterium exchange mass spectrometry combined with docking simulation.
Han, Y; Hu, W; Liu, J; Luo, Q; Lv, S; Wang, F; Wu, K; Xiong, S, 2011
)
0.85
"Recent studies showed that sodium acid sulfate (SAS) and levulinic acid (LA) in combination with sodium dodecyl sulfate (SDS) was effective in inactivating human pathogens on Romaine lettuce."( Acids in combination with sodium dodecyl sulfate caused quality deterioration of fresh-cut iceberg lettuce during storage in modified atmosphere package.
Fan, X; Guan, W; Huang, L, 2010
)
0.88
"A new type of flow injection analysis (FIA) system combined with an extremely high temperature reactor, namely hydrothermal flow injection analysis (HT-FIA), has been successfully constructed for the first time."( Flow injection analysis combined with a hydrothermal flow reactor: application to kinetic determination of trace amounts of iridium using a water-soluble porphyrin.
Hisamoto, H; Igarashi, S; Ikoma, K; Kawamura, K; Yao, T, 2011
)
0.37
"The free energy profiles, ΔG(r), for penetration of methane and water molecules into sodium dodecyl sulfate (SDS) micelles have been calculated as a function of distance r from the SDS micelle to the methane and water molecules, using the thermodynamic integration method combined with molecular dynamics calculations."( Free energy profiles for penetration of methane and water molecules into spherical sodium dodecyl sulfate micelles obtained using the thermodynamic integration method combined with molecular dynamics calculations.
Fujimoto, K; Okazaki, S; Yoshii, N, 2012
)
0.83
"Micellar electrokinetic chromatography fingerprinting combined with quantification was successfully developed and applied to monitor the quality consistency of Weibizhi tablets, which is a classical compound preparation used to treat gastric ulcers."( Monitoring the quality consistency of Weibizhi tablets by micellar electrokinetic chromatography fingerprints combined with multivariate statistical analyses, the simple quantified ratio fingerprint method, and the fingerprint-efficacy relationship.
Liu, Y; Sun, G; Wang, Y; Yang, F; Yang, L, 2015
)
0.42
"The on-line preconcentration technique of field-enhanced sample stacking and sweeping (FESS-sweeping) are combined with dispersive liquid-liquid microextraction (DLLME) to monitor the concentrations of finasteride, which is used in the treatment of androgenetic alopecia, and its metabolite, finasteride carboxylic acid (M3), in urine samples."( Determination of finasteride and its metabolite in urine by dispersive liquid-liquid microextraction combined with field-enhanced sample stacking and sweeping.
Chao, YY; Chen, CH; Chen, YL; Lin, YH, 2018
)
0.48
" We therefore suggest that future studies should focus on elucidating the complex interplay between chemotherapy in combination with luminal irritants on the intestinal permeability of other probes."( Chemotherapeutics Combined with Luminal Irritants: Effects on Small-Intestinal Mannitol Permeability and Villus Length in Rats.
Cano-Cebrián, MJ; Dahlgren, D; Kullenberg, F; Lennernäs, H; Olander, T; Peters, K; Sjöblom, M, 2022
)
0.72
" More than 11,700 proteins were identified in the whole-cell lysate of the CaSki cell line by using the fractionator combined with the filter-aided sample preparation method and mass spectrometry analysis."( Gel electrophoresis/electroelution sorting fractionator combined with filter-aided sample preparation for deep proteomic analysis.
Almeida, A; Besada, V; Carpio, J; González, LJ; Perera, Y; Ramos, Y; Rodríguez-Ulloa, A; Wiśniewski, JR, 2022
)
0.72

Bioavailability

We synthesized atovaquone nanosuspensions (ANSs) coated with poloxamer 188 (P188) and sodium dodecyl sulfate (SDS) to improve oral bioavailability and passage through the blood-brain barrier. In addition, the D-PL/TG NPs with SDS modification on the surface have enhanced stability in the GI tract and increased oralBioavailability of doxorubicin.

ExcerptReferenceRelevance
" This represents a tentative picture of the possible events taking place within the membrane and modifying the absorption rate of a drug, when it is associated with surfactants in a pharmaceutical preparation."( Effect of surfactant monomers on chloramphenicol association to an albumin-lecithin complex: a model for modified drug absorption.
Alhaique, F; Giacchetti, D; Marchetti, M; Riccieri, FM, 1975
)
0.25
" The results demonstrate an improved bioavailability with respect to the insoluble substance."( A soluble mepartricin complex (SPA-S-222) of potential oral and parenteral utility in fungal and protozoal infections.
Bianchi, C; Bruzzese, T; Goi, A; Racchelli, L; Recusani, F, 1976
)
0.26
" In the intact cell extracellular K+ and luminal pH may interact to modify catalytic turnover rate as well as bioavailability of Na(+)-K(+)-ATPase."( Extracellular pH modifies adaptive response to high K+ in cultured canine kidney cells.
Lorenz, JM; Manuli, MA, 1992
)
0.28
" Absolute bioavailability can be modulated by different formulations."( An original intragastric delivery system for oral administration of solid formulations to fully conscious rats: its application to oxodipine studies.
Dufour, A; Egros, F; Hulot, T; Lhot, O; Stypulkowski, M, 1991
)
0.28
"Absorption promoters, or adjuvants, are used to enhance the gastrointestinal absorption of poorly absorbed drugs such as macromolecules."( The reversibility of absorption promoter interaction with red blood cell membranes studied with differential scanning calorimetry.
Ando, HY; Holinej, J; Snow, JW, 1988
)
0.27
" The apparent first-order absorption rate constants for the free antibiotic fraction were determined in free solution, and in the presence of variable surfactant concentration in luminal fluid."( Experimental studies on the influence of surfactants on intestinal absorption of drugs. Cefadroxil as model drug and sodium lauryl sulfate as model surfactant: studies in rat duodenum.
Bengochea, M; Casabó, VG; Fabra-Campos, S; Martín-Villodre, A; Martínez-Cámara, MJ; Sancho-Chust, V, 1995
)
0.29
" Micelle solubilization of cefadroxil was also previously assessed through dialysis tests in order to adequately correct absorption rate constant values found in the presence of the surfactant at supramicellar concentration."( Experimental studies on the influence of surfactants on intestinal absorption of drugs. Cefadroxil as model drug and sodium lauryl sulfate as model surfactant: studies in rat colon.
Bengochea, M; Fabra-Campos, S; Gómez-Meseguer, V; Martín-Villodre, A; Sancho-Chust, V, 1995
)
0.29
" The results imply a decreased bioavailability of SLS in the statin-treated group, while no evidence for an altered permeability barrier to water was found."( Effect of systemic treatment with cholesterol-lowering drugs on the skin barrier function in humans.
Agner, E; Agner, T; Malinowski, J; Meibom, J; Ramsing, D, 1995
)
0.29
" Absorption rate constants of amiodarone decreased as surfactant concentration increased, the absorption being unusually fast at lower surfactant concentrations."( Effects of surfactants on amiodarone intestinal absorption. I. Sodium laurylsulfate.
Casabó, VG; Martín-Algarra, RV; Merino, M; Pascual-Costa, RM, 1994
)
0.29
" These tablets were also tested in a bioavailability study together with an oral solution."( Evaluation of solubilizers in the drug release testing of hydrophilic matrix extended-release tablets of felodipine.
Abrahamsson, B; Johansson, D; Torstensson, A; Wingstrand, K, 1994
)
0.29
" Thus, it is used in transepidermal, nasal, and ocular drug delivery systems and to enhance the intestinal absorption of poorly absorbed drugs; enhancement is concentration dependent."( Fate and effects of the surfactant sodium dodecyl sulfate.
Singer, MM; Tjeerdema, RS, 1993
)
0.56
"To improve the bioavailability of ibuprofen, a thorough preformulation trial was undertaken."( Product development studies on the tablet formulation of ibuprofen to improve bioavailability.
Chatterjee, M; Ghosh, LK; Ghosh, NC; Gupta, BK, 1998
)
0.3
"The purpose of this work was to develop a solid dispersion system containing cyclosporin A (CsA) in order to improve the bioavailability of poorly water-soluble CsA."( Bioavailability of cyclosporin A dispersed in sodium lauryl sulfate-dextrin based solid microspheres.
Choi, HG; Kim, CK; Lee, EJ; Lee, SW, 2001
)
0.31
" Finally, the net absorption rate increased because the solubilization effects of micelles exceeded the reduction effects of mass transfer coefficient above the CMC."( Enhanced naphthalene solubility in the presence of sodium dodecyl sulfate: effect of critical micelle concentration.
Huang, HL; Lee, WM, 2001
)
0.56
" As the magnitude of the micelle solubilization effect was greater than the reduction of the mass transfer coefficient in the presence of the surfactant, the total gas absorption rate increased."( Simultaneous absorption of vapor phase polycyclic aromatic hydrocarbon and carbon dioxide in anionic surfactant solutions.
Huang, HL; Lee, WM, 2001
)
0.31
" The in vitro dissolution results were compared with the in vivo bioavailability for selecting a bio-relevant medium."( Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
Khan, SU; Muhammad, NA; Tang, L, 2001
)
0.31
" To improve the bioavailability of this peptide, two lipidic analogues of MII have been synthesized, the first by coupling 2-amino-d,l-dodecanoic acid (Laa) to the N terminus (LaaMII) and the second by replacing Asn5 in the MII sequence with this lipoamino acid (5LaaMII)."( Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
Adams, DJ; Alewood, PF; Blanchfield, JT; Craik, DJ; Dutton, JL; Gallagher, OP; Hogg, RC; Jones, A; Lewis, RJ; Toth, I, 2003
)
0.32
" Pharmacokinetic and bioavailability study in eight human subjects were performed by HPLC method."( [Studies on diclofenac sodium pulsatile release pellets].
Dang, DS; Guo, T; Song, HT; Sui, Y; Sun, XH; Zheng, CL, 2003
)
0.32
"8 h, and the bioavailability was (91 +/- 12)%."( [Studies on diclofenac sodium pulsatile release pellets].
Dang, DS; Guo, T; Song, HT; Sui, Y; Sun, XH; Zheng, CL, 2003
)
0.32
" Here, a novel method is developed for evaluating the bioavailability of such hydrophobic organic pollutants by considering the digestive guts in deposit-feeding polychaetes."( A novel method for evaluating bioavailability of polycyclic aromatic hydrocarbons in sediments of an urban stream.
Baun, A; Ledin, A; Mikkelsen, PS; Nakajima, F, 2005
)
0.33
" We concluded that sodium lauryl sulfate can be considered as a relatively safe permeation enhancer for amoxicillin in drug delivery systems intended to improve oral bioavailability of this drug."( The evaluation of some pharmaceutically acceptable excipients as permeation enhancers for amoxicillin.
Kerc, J; Kracun, M; Legen, I; Salobir, M, 2006
)
0.33
" However, its poor water-solubility unfortunately results in poor bioavailability and hampers it from being studied and used for possible clinical application."( Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding.
Ho, PC; Wu, JZ, 2006
)
0.33
"Atazanavir (ATV) is a low oral bioavailability (BA) compound and, clinically, is generally coadministrated with ritonavir (RTV), which boosts the oral BA of ATV by inhibiting cytochrome P450 (CYP) 3A, and P-glycoprotein (Pgp) via the same metabolic pathway."( Pharmaceutical approach to HIV protease inhibitor atazanavir for bioavailability enhancement based on solid dispersion system.
Fukushima, K; Haraya, K; Ito, Y; Kodera, S; Seki, Y; Shibata, N; Sugioka, N; Takada, K; Terasaka, S; Wada, A, 2007
)
0.34
" However, pellets with higher coating level and correspondingly longer lag time showed decreased bioavailability of acetaminophen."( In vitro and in vivo performance of a multiparticulate pulsatile drug delivery system.
Dashevsky, A; Mohamad, A, 2007
)
0.34
"The purpose of this investigation was to study the influences of absorption enhancers in increasing oral bioavailability of Ganciclovir (GAN) by assessing the transepithelial permeation across cell monolayers in vitro and bioavailability in rats in vivo."( Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P, 2007
)
0.34
" Absorption rate constants were determined by the plot of log remaining amount of drug in perfusate vs."( Absorptive profile of chlorogenic acid in rats.
Chen, Z; Jiang, X; Li, C; Li, K; Ma, G; Ren, J, 2007
)
0.34
"To evaluate absorption barrier recovery in the gastrointestinal tract after treatment with a penetration enhancer by using a poorly absorbed marker and correlate results with morphological recovery."( Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.
Albrecht, R; Bleher, R; Burnette, R; Kandela, A; Narkar, Y; Robinson, JR, 2008
)
0.35
"Absorption barrier recovery could be measured using a poorly absorbed marker."( Evaluation of mucosal damage and recovery in the gastrointestinal tract of rats by a penetration enhancer.
Albrecht, R; Bleher, R; Burnette, R; Kandela, A; Narkar, Y; Robinson, JR, 2008
)
0.35
" Significantly improved permeation of acyclovir in the presence of selected combinations of absorption enhancers may be used as a viable approach in overcoming the problem of limited oral bioavailability of acyclovir."( In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P, 2008
)
0.35
" Variable dissolution of T4 products can, therefore, impact the oral absorption and bioavailability of T4 and may result in bioequivalence problems between various available products."( A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry.
Akhlaghi, F; Pabla, D; Zia, H, 2009
)
0.35
" We synthesized atovaquone nanosuspensions (ANSs) coated with poloxamer 188 (P188) and sodium dodecyl sulfate (SDS) to improve oral bioavailability and passage through the blood-brain barrier (BBB)."( SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.
Borner, K; Fitzner, R; Heimesaat, MM; Lachenmaier, S; Liesenfeld, O; Lohman, U; Mauludin, R; Mueller, RH; Shubar, HM, 2011
)
0.59
"New drug substances from early development are often poorly water-soluble, which causes poor bioavailability upon peroral administration and hampers drug administration through other routes such as the parenteral or ocular routes."( Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.
Cerdeira, AM; Gander, B; Mazzotti, M, 2010
)
0.36
" Optimised FFB SMEDDS formulations were then selected for in-vivo bioavailability study."( Characterisation of fenofibrate dissolution delivered by a self-microemulsifying drug-delivery system.
Chen, CH; Chen, ET; Ho, HO; Ke, WT; Sheu, MT; Wei, JD, 2010
)
0.36
"In the present study surfactant addition with the help of either a mechanical dispersion or a thermal treatment was applied in order to increase the solubility and the bioavailability of phenanthrene in aqueous media, and therefore to promote its biodegradation."( Effect of surfactants, dispersion and temperature on solubility and biodegradation of phenanthrene in aqueous media.
Blanchard, F; Boudrant, J; Delaunay, S; Goergen, JL; Guédon, E; Guseva, E; Pantsyrnaya, T, 2011
)
0.37
"Micronization is the most effective way to enhance the dissolution rate of poorly water-soluble drugs and bioavailability in human body."( Enhancement of dissolution rate of mitotane and warfarin prepared by using microemulsion systems.
Chen, LJ; Chen, YS; Lin, YH; Wu, TC, 2011
)
0.37
" The aim of the present work was to enhance dissolution and oral bioavailability of poorly water-soluble celecoxib (CXB) by preparing stable CXB nanoparticles using a promising method, meanwhile, investigate the mechanism of increasing dissolution of CXB."( Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Hao, Y; Jiang, T; Liu, Y; Sun, C; Wang, S; Zheng, L, 2010
)
0.36
" Additionally, the studies of in-vitro drug dissolution and oral bioavailability in beagle dogs of nanoparticles were performed."( Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Hao, Y; Jiang, T; Liu, Y; Sun, C; Wang, S; Zheng, L, 2010
)
0.36
"The process by combining the antisolvent precipitation under sonication and HPH was a promising method to produce small, uniform and stable CXB nanoparticles with markedly enhanced dissolution rate and oral bioavailability due to an increased solubility that is attributed to a combination of amorphization and nanonization with increased surface area, improved wettability and reduced diffusion pathway."( Mechanism of dissolution enhancement and bioavailability of poorly water soluble celecoxib by preparing stable amorphous nanoparticles.
Hao, Y; Jiang, T; Liu, Y; Sun, C; Wang, S; Zheng, L, 2010
)
0.36
" The higher efficiency of the extracted chains of magnetosomes compared with that of the other nanoparticles is attributed to three factors: (i) a specific absorption rate higher for the magnetosomes than for the chemically synthesized superparamagnetic iron oxide nanoparticles, (ii) a more uniform heating for the chains of magnetosomes than for the individual magnetosomes and (iii) the ability of the chains of magnetosomes to penetrate within the cancer cells or bind at the cell membrane following the application of the alternative magnetic field, which enables efficient cell destruction."( Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy.
Alphandéry, E; Chebbi, I; Faure, S; Guyot, F; Seksek, O, 2011
)
0.37
"Phosphorylation of l-serine-containing enkephalin analogs has been explored as an alternative to glycosylation in an effort to increase blood-brain barrier permeability and CNS bioavailability of peptide pharmacophores."( Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments.
Abrell, L; Bidlack, JM; Bilsky, EJ; Knapp, BI; Lin, G; Lowery, JJ; Martinez, HN; Muthu, D; Polt, R; Strom, K; Yeomans, L, 2011
)
0.37
" Because docetaxel has a very low permeability and a very low aqueous solubility (biopharmaceutical classification system class IV), a pharmacokinetic booster was combined with a newly developed solid dispersion formulation to improve the oral bioavailability of docetaxel."( Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
Beijnen, JH; Huitema, AD; Koolen, SL; Moes, JJ; Nuijen, B; Schellens, JH, 2011
)
0.37
"With the aim of developing a novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes, various valsartan-loaded solid dispersions were prepared with water, hydroxypropyl methylcellulose (HPMC) and sodium lauryl sulphate (SLS)."( Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
Choi, HG; Kim, DW; Kim, JO; Kim, KK; Lee, BJ; Sung, JH; Yan, YD; Yong, CS, 2012
)
0.38
"Interactions of macrolide antibiotics with biological membranes contribute to their bioavailability but are also involved in the formation of phospholipidosis, which is caused by the inhibition of phospholipase A(1) activity."( Probing the interactions of macrolide antibiotics with membrane-mimetics by NMR spectroscopy.
Göbl, C; Kosol, S; Krajačić, MB; Meyer, NH; Novak, P; Rechberger, GN; Schrank, E; Wagner, GE; Zangger, K, 2012
)
0.38
" The objective of this study was to establish if the test results for an artificial liposome membrane can be extrapolated to determine the actual bioavailability of active substances."( Artificial membranes as models in penetration investigations.
Arct, J; Cetner, B; Krulikowska, M; Lucova, M; Majewski, S, 2013
)
0.39
" We increased the oral bioavailability of paclitaxel by combining a pharmacokinetic booster, ritonavir, with a new oral solid dispersion formulation of paclitaxel."( Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Beijnen, J; Huitema, A; Koolen, S; Moes, J; Nuijen, B; Schellens, J, 2013
)
0.39
"The solubility, absorption and distribution of a drug are involved in the basic aspects of oral bioavailability Solubility is an essential characteristic and influences the efficiency of the drug."( Preparation of candesartan and atorvastatin nanoparticles by solvent evaporation.
Dohnal, J; Grunwaldova, V; Jampilek, J; Kral, V; Vaculikova, E, 2012
)
0.38
"Miconazole and itraconazole possess adequate membrane permeability, but only slight water solubility, which limits their bioavailability and antifungal effect."( Formulation and drying of miconazole and itraconazole nanosuspensions.
Cerdeira, AM; Gander, B; Mazzotti, M, 2013
)
0.39
"The purpose of this study was to develop NS of efavirenz (EFV) and to investigate its potential in enhancing the oral bioavailability of EFV."( Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel, GV; Patel, VB; Pathak, A; Rajput, SJ, 2014
)
0.4
"Thus, it can be concluded that NS formulation of EFV can provide improved oral bioavailability due to enhanced solubility, dissolution velocity, permeability and hence absorption."( Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization, in vitro, in situ and in vivo evaluation.
Patel, GV; Patel, VB; Pathak, A; Rajput, SJ, 2014
)
0.4
"375, low solubility (practically insoluble in water) and low oral bioavailability (36%)."( Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
Baria, RK; Gattani, SG; Ige, PP, 2013
)
0.39
" In rats, the oral bioavailability of dutasteride increased with the supersaturation induced by the HP-β-CD nanostructures."( Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.
Kim, MS, 2013
)
0.39
" In conclusion, the release properties and oral bioavailability of albendazole were greatly improved by using spraydried chitosan-sodium lauryl sulphate microparticles."( Chitosan microparticles: influence of the gelation process on the release profile and oral bioavailability of albendazole, a class II compound.
Bolmaro, RE; García, A; Lamas, MC; Leonardi, D; Mamprin, ME; Piccirilli, GN; Salomón, CJ, 2014
)
0.4
"BCS class III hydrophilic compounds are often associated with low oral bioavailability due to their poor epithelial permeability in the gastrointestinal tract."( Enhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulation.
Dai, WG; Dong, LC; Song, Y, 2013
)
0.39
" These positive attributes can help development of smaller, high drug-loaded dosage forms having enhanced bioavailability and better patient compliance."( Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Azad, M; Bhakay, A; Bilgili, E; Dave, R, 2014
)
0.4
" The dissolution, contact angle and water absorption rate of these solid dispersions were measured to elucidate the relationship between wettability and dissolution."( Understanding the relationship between wettability and dissolution of solid dispersion.
Lian, R; Lu, Y; Qi, J; Tang, N; Wu, W, 2014
)
0.4
" At the concentrations of 20 to 80 microg x mL(-1), the difference of absorption rate constants (K(a)) was not statistically significant."( [Enhancers on the transmembrane transport of chlorogenic acid].
Deng, SQ; Jiang, XH; Ren, J; Wang, LL; Xiao, Y, 2014
)
0.4
"The purpose of this study was to investigate the influence of gastric emptying patterns, surfactants, and dosage form on the supersaturation of a poorly soluble weakly basic drug, dipyridamole, using an in vitro model mimicking the dynamic environment of the upper gastrointestinal tract, and, furthermore, to evaluate the usefulness of this model in establishing correlations to in vivo bioavailability for drugs with solubility/dissolution limited absorption."( Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Fadda, HM; Mitra, A, 2014
)
0.4
"Nanopharmaceuticals (NPs) have emerged as an attractive formulation strategy for bioavailability enhancement of poorly soluble drugs."( Continuous and sustainable granulation of nanopharmaceuticals by spray coagulation encapsulation in alginate.
Hadinoto, K; Yang, Y, 2014
)
0.4
"The objectives of the present study were to formulate and optimize different sized liquid and solid nanocrystalline formulations and evaluate their in vitro and in vivo performance to determine the effect of particle size on the oral bioavailability of solid nanocrystalline formulations."( In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
Burgess, DJ; Jog, R; Kumar, S; Sadrieh, N; Shen, J; Zolnik, B, 2015
)
0.42
" The aim of this study is to investigate the impact of various classes of dispersants on drug dissolution from drug NCMPs, with the ultimate goal of enhancing the bioavailability of poorly water-soluble drugs via high drug nanoparticle loaded, surfactant-free NCMPs."( Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
Abdelmalek, B; Arteaga, C; Azad, M; Bilgili, E; Davé, R, 2015
)
0.42
"One approach for the enhancement of oral drug bioavailability is the technique of nanoparticle preparation."( Preparation of risedronate nanoparticles by solvent evaporation technique.
Dedkova, K; Devinsky, F; Jampilek, J; Peikertova, P; Pisarcik, M; Placha, D; Vaculikova, E, 2014
)
0.4
"0-fold greater bioavailability (p<0."( Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Ahn, HI; Cho, HR; Choi, YS; Ho, MJ; Jung, HJ; Kang, MJ; Lee, DR; Park, JS; Park, JY, 2016
)
0.43
" Sodium citrate, SDS and deoxysodium cholate serve as excellent absorption enhancers which are useful for the related research improving the oral bioavailability of OMT."( Absorption mechanism of oxymatrine in cultured Madin-Darby canine kidney cell monolayers.
Cen, MF; Cheng, XG; Huang, LH; Wang, GX; Wang, SJ; Xiong, XH; Zang, LQ; Zhong, YM, 2016
)
0.43
" In the case of acyclovir, Cap-Na either alone or in combination with SLS or chitosan has the potential to improve its absorption and bioavailability and has yet to be explored."( Effect of permeability enhancers on paracellular permeability of acyclovir.
Ates, M; Kaynak, MS; Sahin, S, 2016
)
0.43
" In addition, the D-PL/TG NPs with sodium dodecyl sulfate modification on the surface have enhanced stability in the GI tract and increased oral bioavailability of doxorubicin."( Sodium Dodecyl Sulfate-Modified Doxorubicin-Loaded Chitosan-Lipid Nanocarrier with Multi Polysaccharide-Lecithin Nanoarchitecture for Augmented Bioavailability and Stability of Oral Administration In Vitro and In Vivo.
Chen, SY; Chen, YP; Chiang, MY; Hsu, CH; Li, WM; Lin, YL; Su, CW; Tsai, NM, 2016
)
2.15
" This study aims to understand the impact of SLS on the solution behavior and bioavailability of hypromellose acetate succinate (HPMC-AS)-based posaconazole (PSZ) ASDs, and to identify the underlying mechanisms governing the optimal oral bioavailability of ASDs when surfactants such as SLS are used in combination."( Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen, Y; Hageman, M; Haskell, R; Hussain, M; Liu, C; Qian, F; Stefanski, K; Su, C; Wang, S, 2016
)
0.43
"The aim of this study was to assess the effect of d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on the physicochemical characterization and oral bioavailability of a novel l-sulpiride-loaded quaternary microcapsule (QMC)."( Development of a novel l-sulpiride-loaded quaternary microcapsule: Effect of TPGS as an absorption enhancer on physicochemical characterization and oral bioavailability.
Choi, HG; Choi, JS; Jin, SG; Kim, DS; Kim, DW; Kim, JO; Kim, KS; Oh, KT; Seo, YG; Yong, CS; Youn, YS, 2016
)
0.43
"Structural transitions involving shape changes play an important role in cellular physiology and enhance the bioavailability of the natural food like curcumin in surfactant aggregates."( Localization and dynamics of the anticarcinogenic curcumin with GM
Chakrabarti, A; Mandal, M; Mukhopadhyay, C; Patra, M, 2017
)
0.46
"Elacridar is highly demanded for proof-of-concept clinical trials that study the drug's suitability to boost brain penetration and bioavailability of numerous anticancer agents."( Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
Beijnen, JH; Nuijen, B; Sawicki, E; Schellens, JH, 2017
)
0.46
"Carvedilol (CAR) in its pure state has low aqueous solubility and extremely poor bioavailability which largely limit its clinical application."( Comparative study on stabilizing ability of food protein, non-ionic surfactant and anionic surfactant on BCS type II drug carvedilol loaded nanosuspension: Physicochemical and pharmacokinetic investigation.
Banerjee, P; Geng, T; Li, T; Lu, Z; Wang, B; Zoghbi, A, 2017
)
0.46
"The purpose of this study was to assess the impact of inorganic mesoporous carriers on the physicochemical properties and oral bioavailability of 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG)-loaded solid self-emulsifying drug delivery system (solid SEDDS)."( Effect of inorganic mesoporous carriers on 1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol-loaded solid self-emulsifying drug delivery system: Physicochemical characterization and bioavailability in rats.
Choi, HG; Jin, SG; Kim, DS; Kim, JO; Li, DX; Oh, KT; Yang, ES; Yong, CS; Youn, YS, 2017
)
0.46
"Supersaturating drug delivery systems (SDDS), as solid dispersions (SDs), stand out among strategies to enhance bioavailability of poorly soluble drugs."( Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França, MT; Klüppel Riekes, M; Munari Oliveira Pinto, J; Nicolay Pereira, R; Stulzer, HK, 2018
)
0.48
" However, this system presents a bioavailability of less than 20% for insulin encapsulation."( Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system.
Auberval, N; Bietiger, W; Czuba, E; Diop, M; Frere, Y; Julien-David, D; Langlois, A; Maillard, E; Marchioni, E; Mura, C; Neidl, R; Pinget, M; Schaschkow, A; Sigrist, S; Virciglio, A, 2018
)
0.48
" Some of these excipients increase intestinal permeability, and subsequently the absorption and bioavailability of the drug."( The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs.
Dahlgren, D; Johansson, P; Langguth, P; Lennernäs, H; Lundqvist, A; Roos, C; Sjöblom, M; Sjögren, E; Tannergren, C, 2018
)
0.48
"The aim of this study was to improve the oral bioavailability of a practically insoluble drug, efonidipine hydrochloride (EFH), by agglomeration in acid solution/gastric fluid."( Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method.
Cheng, G; Huang, S; Li, H; Piao, H; Sun, Y; Zhang, Q; Zou, M, 2018
)
0.48
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" This study demonstrates successful preparation of fast supersaturating (190% within 20 min) HyNASDs, which renders nanoparticle formulations competitive to ASDs in bioavailability enhancement of poorly soluble drugs."( Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Arevalo, F; Bilgili, E; Coelho, A; Rahman, M, 2019
)
0.51
"Previous studies have shown that curcumin (Cur) induced by ultrasound has protective effects on atherosclerosis even if low bioavailability of the Cur."( Sonodynamic therapy in atherosclerosis by curcumin nanosuspensions: Preparation design, efficacy evaluation, and mechanisms analysis.
Chen, Z; Hu, D; Jiang, J; Jiang, L; Lian, M; Liu, X; Peng, H; Wang, J; Wang, N; Zhang, C; Zhao, M, 2020
)
0.56
"Drug delivery vehicles such as micelles, vesicles and other nanoemulsions are necessary for enhanced bioavailability of drugs in the body."( Partitioning of anticancer drug 5-fluorouracil in micellar media explored by physicochemical properties and energetics of interactions: Quantitative insights for implications in drug delivery.
Dasgupta, M; Judy, E; Kishore, N, 2020
)
0.56
"Lyophilized nanosuspension of poorly soluble Ethinyl estradiol (EE) was fabricated to enhance its solubility and bioavailability using a quality-by-design (QbD) approach."( QbD Based Approach to Enhance the In-Vivo Bioavailability of Ethinyl Estradiol in Sprague-Dawley Rats.
Hajare, AA; Powar, TA, 2020
)
0.56
" In this study, we employed sodium dodecyl sulfate (SDS), an efficient tight junction opening agent, to modify the surface of luteolin nanocrystals, aiming to enhance the bioavailability of luteolin (LUT) and luteolin nanocrystals (LNC)."( Improving Oral Bioavailability of Luteolin Nanocrystals by Surface Modification of Sodium Dodecyl Sulfate.
Cheng, M; Feng, J; Gao, C; Jin, Y; Liu, J; Liu, Q; Liu, W; Sun, Y; Tu, L, 2021
)
1.14
"In cosmetic, pharmaceutical, and food applications, many active ingredients have limited bioavailability in an aqueous environment, and in that context, nanoemulsions provide a mechanism for encapsulation, protection, and transport."( Interfacial Steric and Molecular Bonding Effects Contributing to the Stability of Neutrally Charged Nanoemulsions.
Richmond, GL; Tran, E, 2021
)
0.62
"The development of protein-based nanocarriers to improve the water solubility, stability, and bioavailability of hydrophobic or poorly soluble bioactive molecules has attracted increasing interest in the food and pharmaceutical industries."( Sodium Dodecyl Sulfate-Dependent Disassembly and Reassembly of Soybean Lipophilic Protein Nanoparticles: An Environmentally Friendly Nanocarrier for Resveratrol.
Li, Y; Qi, B; Song, H; Sun, Y; Zhang, S; Zhong, M, 2022
)
2.16
"In this work, an amorphous solid dispersion (ASD) formulation was systematically developed to simultaneously enhance bioavailability and mitigate the mechanical instability risk of the selected crystalline form of a development drug candidate, GDC-0334."( Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
Chen, T; Chiang, CW; Chin, S; Hou, HH; Lubach, JW; Ly, J; Nagapudi, K; Zhang, W, 2023
)
0.91

Dosage Studied

Carrier quantitative bactericidal test showed that the addition dosage of gemini fluoronates, sodium dodecyl sulfate surfactant and perfluorinated the nonene oxy benzene sulfonate were 60, 60 and 40 mg/L respectively. The killing log value of Staphylococcus aureus exposed to the disinfectant solution containing chlorine dioxide 50mg/L for 10 mm were all more than 3.

ExcerptRelevanceReference
" All the drugs caused rapid retraction of the neurites, which was reversible in all cases but for sodium dodecyl sulphate, and showed a sigmoid dose-response relationship."( Reversal of morphological differentiation of mouse neuroblastoma cells by mitosis-inhibitors and anesthetics.
Edström, A; Erkell, LJ; Hansson, HA, 1975
)
0.25
" Dose-response relation in serum calcium-lowering activity was examined with a sample purified from the extracts, and a linear dependence of the response to log dose was recognized over a moderate range of doses."( A hypocalcemic and lympnocyte-stimulating substance isolated from thymus extracts, and its physicochemical properties.
Hayase, S; Mizutani Shimizu, M; Mizutani, A; Mizutani, T; Suzuki, I, 1975
)
0.25
" However, under conditions in which the baseline incorporation of isotope of the control and experimental groups does not vary, as in studies of the temporal course of synthesis and dose-response relationships, the use of increases in isotope ratios is adequate for quantitative interpretations."( Studies on the synthesis of estrogen-specific uterine proteins. Comparison of methods of quantitative evaluation of double-isotope peaks.
Mayol, RF, 1975
)
0.25
" Analysis of dose-response curves showed statistically significant increased susceptibility to SLS-induced irritation in patients with seborrhoeic dermatitis and atopic eczema compared with normal subjects."( A dose-response study of irritant reactions to sodium lauryl sulphate in patients with seborrhoeic dermatitis and atopic eczema.
Cowley, NC; Farr, PM, 1992
)
0.28
"The dose-response relationship in patch testing with sodium lauryl sulphate (SLS) was studied."( Sodium lauryl sulphate for irritant patch testing--a dose-response study using bioengineering methods for determination of skin irritation.
Agner, T; Serup, J, 1990
)
0.28
" This increase in elution caused a reduction in the shoulder width of the DNA elution dose-response curve, but did not significantly affect the final slope."( Linear DNA elution dose response curves obtained in CHO cells with non-unwinding filter elution after appropriate selection of the lysis conditions.
Iliakis, G; Okayasu, R, 1989
)
0.28
" The assay was 10 times as sensitive as previously reported immunoassays, the detection limit being approximately 1 pg u-PA in a volume of 100 microliter, with a linear dose-response up to 15 pg u-PA."( Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.
Agerlin, N; Bach, F; Danø, K; Dombernowsky, P; Grøndahl-Hansen, J; Munkholm-Larsen, P; Nielsen, LS, 1988
)
0.27
" This assay is characterized in terms of optimum cell number and pH and dose-response curves for DNA damage and cell survival following ionizing radiation, MNNG, BCNU, and VP-16 are shown."( DNA precipitation assay: a rapid and simple method for detecting DNA damage in mammalian cells.
Olive, PL, 1988
)
0.27
" For comparison, solubilized hepatic cytochromes P-450 were obtained from rats dosed with phenobarbital (PB), beta-naphthoflavone (BNF) or pregnenolone-16 alpha-carbonitrile."( Differences in the constitutive forms of hepatic cytochrome P-450 in male and female adult beagle dogs.
Amacher, DE; Smith, DJ, 1987
)
0.27
" Smooth dose-response curves were obtained."( Skin irritancy from nonanoic acid.
Hietasalo, A; Wahlberg, JE; Wrangsjö, K, 1985
)
0.27
" The dose-response graphs of kidney and skin Na+/K+-ATPase vs ouabain concentrations show that at ouabain concentrations ranging from 1 nM and 1 pM the inhibition elicited by the cardioglycoside disappears and is replaced by an activatory effect."( Na+/K+-ATPase from Xenopus laevis (Daudin) kidney and epidermis: high sensitivity towards regulatory compounds.
De Bortoli, M; Giunta, C; Sanchini, M; Stacchini, A, 1984
)
0.27
" The suggested procedure is applicable to a number of drugs, either as pure compounds or in pharmaceutical dosage forms without prior cleanup."( [Quantitative determination of anxiolytics by high pressure liquid chromatography].
Barbato, F; Silipo, C; Vittoria, A, 1980
)
0.26
" Sodium lauryl sulfate (SLS) and non-anoic acid in different concentrations were applied daily to human and animal (rabbit and guinea pig) skin, and a dose-response relationship established."( Assessment of skin irritancy: measurement of skin fold thickness.
Wahlberg, JE, 1983
)
0.27
" This study illustrates that PGE2 dose-response curves may reflect different mechanisms of action that may be intimately associated with skin irritant and tumour promoting activity."( Comparison of tumour promoter-induced prostaglandin E2 release in human and rat keratinocytes.
Benford, DJ; Lawrence, JN, 1995
)
0.29
"To quantify the dose-response relation of irritant-induced erythema, we examined inflammation in human skin after application of an irritant, using perpendicular polarized photography and diffuse reflectance spectroscopy as compared to clinical visual scoring."( A single parameter, oxygenated hemoglobin, can be used to quantify experimental irritant-induced inflammation.
Drake, LA; Gillies, R; Kollias, N; Muccini, JA; Phillips, SB; Uyeyama, RK, 1995
)
0.29
" To investigate the capabilities of this assay further, a time-course and dose-response were performed with all-trans-retinoic acid, and a comparison made with sodium lauryl sulphate."( An in vivo experimental model for effects of topical retinoic acid in human skin.
Finkel, LJ; Griffiths, CE; Hamilton, TA; Tranfaglia, MG; Voorhees, JJ, 1993
)
0.29
" We conducted a large dose-response study and studied the impact of summer and winter weather on a predictive human assay."( Individual, ethnic and seasonal variability in irritant susceptibility of skin: the implications for a predictive human patch test.
Basketter, DA; Griffiths, HA; McFadden, J; Wang, XM; Wilhelm, KP, 1996
)
0.29
" Therefore, when using surfactants in dissolution media for in vitro testing of dosage forms, consideration must be given to the level of impurities present so that the results are consistent and reliable."( Dissolution media for in vitro testing of water-insoluble drugs: effect of surfactant purity and electrolyte on in vitro dissolution of carbamazepine in aqueous solutions of sodium lauryl sulfate.
Amidon, GL; Crison, JR; Weiner, ND, 1997
)
0.3
" During the 8-week dosing period, a significant increase in mean turnover rates was observed in streams dosed with > or = 61 micrograms C12-alkyl sulfate/liter, despite a 10 degrees C drop in stream temperature."( Stream periphytic biodegradation of the anionic surfactant C12-alkyl sulfate at environmentally relevant concentrations.
Belanger, SE; Davidson, DH; Guckert, JB; Lee, DM; Ventullo, RM, 1997
)
0.3
"A sensitive spectrophotometric assay has been developed for the determination of methoxamine in pure dosage form and in its pharmaceutical preparations."( Spectrophotometric determination of methoxamine using cerium(IV) in presence of sodium lauryl sulphate and rhodamine-B.
al-Obaid, AM; Alwarthan, AA, 1997
)
0.3
" An aqueous acetonitrile (ACN) buffer containing sodium dodecyl sulfate (SDS) surfactant allows resolution of the 15 taxanes from each other and from the principal matrix ingredient in the injectable dosage form of the drug, Cremophor EL (polyethoxylated castor oil)."( Separation of paclitaxel and related taxanes by micellar electrokinetic capillary chromatography.
Locke, DC; Shao, LK, 1998
)
0.55
" Even for Type VI skin (n = 25), the dose-response curve fell within the general pattern."( Acute irritation thresholds in subjects with type I--type VI skin.
Basketter, DA; McFadden, JP; Wakelin, SH, 1998
)
0.3
" This dosage can be used to study the barrier properties of the corneocyte layer without destroying the artificial skin."( In vitro correlation between two colorimetric assays and the pyruvic acid consumption by fibroblasts cultured to determine the sodium laurylsulfate cytotoxicity.
Coiffard, C; Coiffard, LJ; De Roeck-Holtzhauer, Y; Rivalland, P; Verhulst, C, 1998
)
0.3
" Employing the Korsmeyer-Peppas model of Fickian and non-Fickian drug release, it was further shown that release of the drug from the dosage form was governed largely by surface erosion of the surfactant-enriched tablet matrix."( Design and characterization of a surfactant-enriched tablet formulation for oral delivery of a poorly water-soluble immunosuppressive agent.
Grim, YA; Matuszewska, BK; Ostovic, D; Ruddy, SB; Storey, DE, 1999
)
0.3
" Microdialysis sampling in anatomical regions remote from the dosed site excluded the possibility that SA levels measured were due to systemic absorption."( Effect of barrier perturbation on cutaneous penetration of salicylic acid in hairless rats: in vivo pharmacokinetics using microdialysis and non-invasive quantification of barrier function.
Benfeldt, E; Serup, J, 1999
)
0.3
"06 M SDS-8%, propanol was preferred to assay furosemide in several dosage forms (tablets, capsules, injectables and drops)."( Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug.
Carda-Broch, S; Esteve-Romero, J; García-Alvarez-Coque, MC, 2000
)
0.31
" This assay may be used for the determination of purity, identity and strength for the active ingredient and finished dosage forms."( Ranitidine hydrochloride: development of an isocratic stability--indicating high-performance liquid chromatographic separation.
Munro, JS; Walker, TA, 2001
)
0.31
" Sperms were dosed separately with different concentrations of SDS and LAS for 60 minutes."( Acute toxicity of anionic surfactants sodium dodecyl sulphate (SDS) and linear alkylbenzene sulphonate (LAS) on the fertilizing capability of gilthead (Sparus aurata L.) sperm.
Carrasco, C; Ordóñez, FJ; Ribelles, A; Rosety, I; Rosety, JM; Rosety, M; Rosety-Rodríguez, M, 2001
)
0.31
" Clear dose-response relationships for mortality of gilthead eggs was observed for both toxicants; at 30 mg/L 50% mortality took place at 45 minutes for ABS and 8 minutes for SDS."( Comparative study of the acute toxicity of anionic surfactans alkyl benzene sulphonate (ABS) and sodium dodecyl sulphate (SDS) on gilthead, Sparus aurata L., eggs.
Carrasco, C; Ordoñez, FJ; Ribelles, A; Rosety, I; Rosety, JM; Rosety, M; Rosety-Rodríguez, M, 2001
)
0.31
" The methods used included a modified rotating disk apparatus for measuring intrinsic dissolution rate of the new chemical entity (NCE) and the USP dissolution method II for evaluating dissolution profiles of the drug in three different dosage forms."( Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity.
Khan, SU; Muhammad, NA; Tang, L, 2001
)
0.31
" Sample analysis was performed by using standard addition method to eliminate the matrix effects of dosage vehicle."( Determination of recombinant human epidermal growth factor (rhEGF) in a pharmaceutical preparation by capillary electrophoresis.
Chung, YB; Han, K; Hwang, KH; Kim, CS; Lee, KW; Moon, DC, 2001
)
0.31
"001) in all the surfactant exposed fish, but the renal enzyme was significantly increased only in CTAB dosed fish (P<0."( Surfactant-induced lipid peroxidation in a tropical euryhaline teleost Oreochromis mossambicus (Tilapia) adapted to fresh water.
Babu, P; Bindu, PC, 2001
)
0.31
"A micellar electrokinetic chromatographic (MEKC) method was developed for the quantification of celecoxib, a COX-2 inhibitor in pharmaceutical dosage forms within the total analysis time of 7 min."( Determination of celecoxib, a COX-2 inhibitor, in pharmaceutical dosage forms by MEKC.
Reddy, GO; Sreenivas Rao, D; Srinivasu, MK, 2002
)
0.31
" SDS treatment with dosages of 10% and higher resulted in a SI above 3, while a dosage of 1% SDS showed no activity."( Determination of the sensitising activity of the rubber contact sensitisers TMTD, ZDMC, MBT and DEA in a modified local lymph node assay and the effect of sodium dodecyl sulfate pretreatment on local lymph node responses.
De Jong, WH; Spiekstra, SW; Tentij, M; Van Loveren, H; Vandebriel, RJ, 2002
)
0.51
" In the present study, the combined effect of an irritant and an allergen was evaluated in a dose-response designed experimental study."( Combined effects of irritants and allergens. Synergistic effects of nickel and sodium lauryl sulfate in nickel- sensitized individuals.
Agner, T; Basketter, D; Johansen, JD; Menné, T; Overgaard, L; Vølund, A, 2002
)
0.31
" In these 8-h, flow-through diffusion studies, PCP was dosed with the following vehicles: 100% EtOH, 100% water, 40% EtOH + 60% water, 40% EtOH + 60% water + SLS, 40% EtOH + 60% water + MNA, and 40% EtOH + 60% water + SLS + MNA."( Effect of chemical interactions in pentachlorophenol mixtures on skin and membrane transport.
Baynes, RE; Brooks, JD; Mumtaz, M; Riviere, JE, 2002
)
0.31
"To determine the appropriate dosage of SDS when extracting membranous labyrinth proteins."( [The dosage of SDS when extracting membranous labyrinth proteins].
Cheng, Q; Gao, Y; Huang, X; Lin, X; Wang, J; Zhang, R, 2003
)
0.32
" Skin reactions were evaluated by clinical scoring, and data were evaluated by logistic dose-response models."( Influence of a detergent on skin response to methyldibromo glutaronitrile in sensitized individuals.
Agner, T; Haslund, P; Held, E; Johansen, JD; Pedersen, LK; Vølund, A, 2004
)
0.32
" This study demonstrated that Tg rasH2 mice can tolerate once or twice daily gavage dosing with water or vehicle containing 1% SDS."( Effect of oral gavage dosing regimens in female Tg rasH2 transgenic mice.
Furst, SM; Hawley, KD; May, JR; Morton, D; Sellers, RS,
)
0.13
" The dosage of SDS required for ECF was much less than those for dispersed air flotation (DiAF) or dissolved air flotation (DAF) processes because the CaF(2) particles can be collected by hydro-fluoro-aluminum flocs in ECF."( Removal of fluoride from semiconductor wastewater by electrocoagulation-flotation.
Hu, CY; Kuan, WH; Lee, YD; Lo, SL, 2005
)
0.33
" Recovery of both the drugs in tablet dosage form and spiked drugs in plasma were > or =99."( Simultaneous determination of HIV-protease inhibitors lamivudine and zidovudine in pharmaceutical formulations by micellar electrokinetic chromatography.
Azhaguvel, S; Sekar, R, 2005
)
0.33
" Our results show that the addition of Triton-X at concentrations greater than its CMC can reduce the SDS dosage required for effective Cu removal, and at the same time, minimize the permeate SDS concentration."( Micellar-enhanced ultrafiltration (MEUF) with mixed surfactants for removing Cu(II) ions.
Li, CW; Liu, CK; Yen, WS, 2006
)
0.33
" Only glycerol showed dose-response and effects potentially better than no treatment."( Anti-irritants I: Dose-response in acute irritation.
Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK, 2006
)
0.33
" The dose-response effect of 4 alleged AI (nifedipine, (-)-alpha-bisabolol, canola oil and glycerol) was studied on experimentally induced acute irritation in healthy volunteers, and only glycerol showed dose-related response and effects potentially better than no treatment."( Anti-irritants II: Efficacy against cumulative irritation.
Andersen, F; Andersen, KE; Bindslev-Jensen, C; Fullerton, A; Hedegaard, K; Petersen, TK, 2006
)
0.33
" Oral aspirin has a repertoire of gastrointestinal side effects even at low doses and requires high frequent dosing because it undergoes extensive presystemic metabolism."( Design of a transdermal delivery system for aspirin as an antithrombotic drug.
Ammar, HO; El-Nahhas, SA; Ghorab, M; Kamel, R, 2006
)
0.33
" The skin reactions were assessed visually, and it was demonstrated that the modality of the reactions in these 2 populations had clear differences, but that the dose-response profiles were very similar."( The effect of population diversity on skin irritation.
Ahmed, S; Basketter, D; Cooper, K; Indra, P; Iyer, JV; Marriott, M; Mukerji, B; Peters, L; Rowson, M; Roy, A, 2006
)
0.33
" Through the printing of release-retardation materials, 3DP processes could easily prepare tablets with high dosage and special design features for furnishing the desired drug release characteristics."( Tablets with material gradients fabricated by three-dimensional printing.
Huang, WD; Liu, J; Wang, YG; Xu, H; Yang, XL; Yu, DG, 2007
)
0.34
" Sperm suspensions (100,000,000 spermatozoa/mL) were dosed separately with different concentrations of SDS (0."( Lipid peroxidation was associated to the impairment of the fertilizing capability of gilthead sperm exposed to surfactants.
Frias, L; Ordoñez, FJ; Rosety, I; Rosety, JM; Rosety, M; Rosety-Rodríguez, M, 2007
)
0.34
" These results provided some useful information on parameters which can be modulated in the design of a controlled release dosage form for NP."( Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol.
Hong, SI; Oh, SY, 2008
)
0.35
"Various methods are available to formulate water soluble drugs into sustained release dosage forms by retarding the dissolution rate."( Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
Hassan-Zadeh, D; Monajjem-Zadeh, F; Nokhodchi, A; Taghi-Zadeh, N, 2008
)
0.35
" Three new dosage forms containing beta-cyclodextrin and surfactants (SDS, ASC8) were compared in the FST with the commercial extract."( Pharmacological in vivo test to evaluate the bioavailability of some St John's Wort innovative oral preparations.
Bergonzi, MC; Bilia, AR; Galeotti, N; Ghelardini, C; Isacchi, B; Vincieri, FF, 2009
)
0.35
" The dissolution of T4 from three commercial solid oral dosage forms: Synthroid (SYN), generic levothyroxine sodium by Sandoz Inc."( A comparative pH-dissolution profile study of selected commercial levothyroxine products using inductively coupled plasma mass spectrometry.
Akhlaghi, F; Pabla, D; Zia, H, 2009
)
0.35
" At low concentration these vesicles have scarce consequences on normal cell growth; at higher dosage they activate apoptotic death processes, due to membrane damage."( Biological activity of SDS-CTAB cat-anionic vesicles in cultured cells and assessment of their cytotoxicity ending in apoptosis.
Aiello, C; Andreozzi, P; La Mesa, C; Risuleo, G, 2010
)
0.36
" Three chemicals with a range of hydrophobicity and volatility were selected and delivered in three different solvents using two common dosing procedures."( Effects of solvents and dosing procedure on chemical toxicity in cell-based in vitro assays.
Busser, FJ; Hermens, JL; Kramer, NI; Rico-Rico, A; Schirmer, K; Tanneberger, K, 2010
)
0.36
"01) following a single dosing and also on repeated dosing in MDFRs."( Evaluation of the specificity and effectiveness of selected oral hygiene actives in salivary biofilm microcosms.
DeVizio, W; Ledder, RG; McBain, AJ; Sreenivasan, PK, 2010
)
0.36
"The impact of the addition of a wetting agent, the surfactant sodium lauryl sulfate (SLS), on the tablet hardness of a dry granulated, solid oral dosage form was investigated."( Improving the hardness of dry granulated tablets containing sodium lauryl sulfate.
Colón, I; Kushner, J; Moore, F; Okelo, G, 2010
)
0.36
" The presence of SDS at sub-cmc decreased TCE degradation by 5%, but increased degradation by 5% when SDS dosage was raised to 5 × cmc."( Degradation of soil-sorbed trichloroethylene by stabilized zero valent iron nanoparticles: effects of sorption, surfactants, and natural organic matter.
Hao, X; He, F; Zhang, M; Zhao, D, 2011
)
0.37
"The poor solubility of astaxanthin in water can cause problems during dissolution tests of dosage forms because they are usually performed in water-based media."( Dissolution and spectrophotometric determination of astaxanthin in aqueous solutions.
Gardavská, K; Halenárová, A; Potúcková, M; Scheerová, ZK; Tichý, E; Zabka, M, 2011
)
0.37
"For use in chronic oral chemotherapeutic regimens, the potent anticancer drug docetaxel needs a solid oral dosage form."( Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001).
Beijnen, JH; Huitema, AD; Koolen, SL; Moes, JJ; Nuijen, B; Schellens, JH, 2011
)
0.37
" Passive dosing was applied to control chemical activities of HOCs in aqueous solutions by equilibrium partitioning from a poly(dimethylsiloxane) polymer preloaded with the chemicals."( Measuring binding and speciation of hydrophobic organic chemicals at controlled freely dissolved concentrations and without phase separation.
de Jonge, LW; Gouliarmou, V; Mayer, P; Smith, KE, 2012
)
0.38
" In summary, in vivo pharmacokinetic evaluation is essential to develop an appropriate in vitro dissolution condition for oral solid dosage forms of poorly soluble drugs."( Considerations in the development of an in vitro dissolution condition for lacidipine tablets: in vivo pharmacokinetic evaluation.
He, S; He, Z; Liu, X; Sun, J; Sun, M; Sun, Y; Wang, Y, 2012
)
0.38
" In addition to this, the favorable pharmaceutical characteristics, for example, neutral taste, dosing accuracy, and the 2-year ambient shelf life, make the ModraPac001 10mg capsule an attractive candidate for oral paclitaxel chemotherapy."( Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
Beijnen, J; Huitema, A; Koolen, S; Moes, J; Nuijen, B; Schellens, J, 2013
)
0.39
" In this work, we consider the dissolution testing of griseofulvin (GF) particles, a poorly water-soluble compound, incorporated into a strip-film dosage form."( Using USP I and USP IV for discriminating dissolution rates of nano- and microparticle-loaded pharmaceutical strip-films.
Bhakay, A; Bilgili, E; Davé, RN; Keyvan, G; Michniak-Kohn, B; Pandya, N; Sievens-Figueroa, L, 2012
)
0.38
" The half maximal effective concentration (EC(50)) was estimated from the dose-response curves and the values indicated an increase in toxicity with the increase in alkyl chain length."( In vitro cytotoxicity of a thermoresponsive gel system combining ethyl(hydroxyethyl) cellulose and lysine-based surfactants.
Araújo, MJ; Calejo, MT; Cardoso, AM; de Lima, MC; Jurado, AS; Kjøniksen, AL; Marques, EF; Nyström, B; Sande, SA, 2013
)
0.39
" Compared with the performance by single SDS, the mixed SDS/Brij 35, SDS/TW80 and SDS/TX100 at an optimum composition could result in not only higher rejection of Cu(2+) but also much less dosage of surfactant and concentration of SDS in the permeate."( Micellar-enhanced ultrafiltration of copper ions using sodium dodecyl sulfate and its mixture with Brij 35, Tween 80 and Triton X-100.
Li, R; Zhang, L; Zhao, B; Zhong, J, 2013
)
0.64
" In conclusion, preparation of dutasteride-loaded HP-β-CD nanostructures using the supercritical antisolvent process affords a viable alternative solid dosage form for dutasteride."( Influence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.
Kim, MS, 2013
)
0.39
" This post-coating drying step is traditionally carried out in static conditions, requiring the transfer of solid dosage forms to an oven."( Comparative static curing versus dynamic curing on tablet coating structures.
Baron, M; Boiret, M; Chaminade, P; Fayard, B; Gendre, C; Genty, M; Lecoq, O; Péan, JM; Tfayli, A, 2013
)
0.39
" These positive attributes can help development of smaller, high drug-loaded dosage forms having enhanced bioavailability and better patient compliance."( Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Azad, M; Bhakay, A; Bilgili, E; Dave, R, 2014
)
0.4
" Dose-response data are typically evaluated by using a log-logistic model that includes EC50 as one of the model parameters."( Summarizing EC50 estimates from multiple dose-response experiments: a comparison of a meta-analysis strategy to a mixed-effects model approach.
Jiang, X; Kopp-Schneider, A, 2014
)
0.4
"The purpose of this study was to investigate the influence of gastric emptying patterns, surfactants, and dosage form on the supersaturation of a poorly soluble weakly basic drug, dipyridamole, using an in vitro model mimicking the dynamic environment of the upper gastrointestinal tract, and, furthermore, to evaluate the usefulness of this model in establishing correlations to in vivo bioavailability for drugs with solubility/dissolution limited absorption."( Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
Fadda, HM; Mitra, A, 2014
)
0.4
" The method was successfully applied to the analysis of EMZ and PRZ in their commercial dosage forms and the results were in good agreement with those obtained with the comparison method."( Enhanced spectrofluorimetric determination of esomeprazole and pantoprazole in dosage forms and spiked human plasma using organized media.
Alaa, H; Belal, F; Sharaf El-Din, M; Tolba, MM, 2015
)
0.42
" Their oral solid dosage form preparation requires them to undergo granulation before they can be processed into tablets."( Continuous and sustainable granulation of nanopharmaceuticals by spray coagulation encapsulation in alginate.
Hadinoto, K; Yang, Y, 2014
)
0.4
" Understanding the formation of surfactant micelles is vital for the applications of biomedicine such as drug fabrication and smart molecular vehicles in delivering therapeutic dosage to various molecular sites."( Fluorophotometric determination of critical micelle concentration (CMC) of ionic and non-ionic surfactants with carbon dots via Stokes shift.
Lavkush Bhaisare, M; Pandey, S; Shahnawaz Khan, M; Talib, A; Wu, HF, 2015
)
0.42
" The proposed IPC method was successfully applied for the determination of pharmaceutical dosage forms without prior need for separation."( An Efficient Ion-Pair Liquid Chromatographic Method for the Determination of Some H2 Receptor Antagonists.
Ahmed, S; Elshaboury, SR; Farrag, S; Mohamed, NA, 2016
)
0.43
" These data suggest that a novel SLS/HPMC SD may be an advantageous dosage form of FK506, boosting the dissolution and absorption in gastrointestinal tract."( Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Ahn, HI; Cho, HR; Choi, YS; Ho, MJ; Jung, HJ; Kang, MJ; Lee, DR; Park, JS; Park, JY, 2016
)
0.43
" A second dose-response experiment was performed using diets supplemented with the saturated-fatty-acid (SFA)-rich coconut oil."( High-fat diets rich in saturated fat protect against azoxymethane/dextran sulfate sodium-induced colon cancer.
Cranford, TL; Davis, JM; Enos, RT; McClellan, JL; Murphy, EA; Nagarkatti, M; Nagarkatti, PS; Velázquez, KT, 2016
)
0.43
"Sodium lauryl sulfate (SLS), as an effective surfactant, is often used as a solubilizer and/or wetting agent in various dosage forms for the purpose of improving the solubility and dissolution of lipophilic, poorly water-soluble drugs."( Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen, Y; Hageman, M; Haskell, R; Hussain, M; Liu, C; Qian, F; Stefanski, K; Su, C; Wang, S, 2016
)
0.43
" The proposed method was successfully applied to the analysis of these drugs in dosage forms."( Bioanalytical method for the estimation of co-administered esomeprazole, leflunomide and ibuprofen in human plasma and in pharmaceutical dosage forms using micellar liquid chromatography.
Talaat, W, 2017
)
0.46
"A new, simple, sensitive and rapid spectrofluorimetric method has been developed for determination of certain adrenergic agonists such as isoxsuprine hydrochloride, ritodrine hydrochloride and etilefrine hydrochloride in their pure forms and pharmaceutical dosage forms."( Spectrofluorimetric determination of certain adrenergic agonist drugs in their pure forms and pharmaceutical formulations: Content uniformity test application.
Attia, TZ; Badr El-Din, KM, 2017
)
0.46
" The powders obtained, which present enhanced dissolution properties, can be incorporated in a solid dosage form for treatment of AIDS in paediatric patients with promising results."( Efavirenz dissolution enhancement III: Colloid milling, pharmacokinetics and electronic tongue evaluation.
Bilatto, SE; Cabral, LM; Corrêa, DS; da Costa, MA; Fandaruff, C; Hoffmeister, CR; Pitta, LR; Prado, LD; Rocha, HV; Silva, MA; Tasso, L, 2017
)
0.46
" This in turn hinders understanding of the driving force for phase transformations and membrane transport, which is essential to better understand supersaturating dosage forms."( Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.
Gao, Y; Indulkar, AS; Mo, H; Raina, SA; Taylor, LS; Zhang, GGZ, 2017
)
0.46
"In the pharmaceutical industry, in vitro dissolution testing ofsolid oral dosage forms is a very important tool for drug development and quality control."( Interactions between a poorly soluble cationic drug and sodium dodecyl sulfate in dissolution medium and their impact on in vitro dissolution behavior.
Fish, WP; Huang, Z; Parikh, S, 2018
)
0.73
" On the basis of these observations, a thorough investigation into the impact of combinations of additives on amorphous drug crystallization during dissolution and stability studies is recommended in order to develop optimized formulations of supersaturating dosage forms."( Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel, S; Cathcart, H; O'Reilly, NJ, 2018
)
0.48
" Data obtained by the study indicated that the medium selection and pH control were important for liquid preparation of ISA, and avoiding dissolution and absorption in stomach was critical for the oral solid dosage forms."( Preformulation study and initial determination of biological Properties of isopropylidene shikimic acid.
Kong, H; Lin, L; Ni, J; Qu, C; Wu, H; Yang, P; Yin, X; Zhang, H; Zhang, X, 2018
)
0.48
" The optimum dosage of CTAB was found to be 1500 mg/L, and resulted in 95."( The effects of surfactants (sodium dodecyl sulfate, triton X-100 and cetyl trimethyl ammonium bromide) on the dewaterability of microalgae biomass using pressure filtration.
Han, M; Hashemi, S; Park, J; Taghavijeloudar, M, 2019
)
0.81
"A fast, simple and sensitive micellar enhanced spectrofluorimetric method is performed for the determination of Daclatasvir dihydrochloride (DAC) in its pharmaceutical dosage form and in spiked human plasma."( Stability-indicating micellar enhanced spectro-fluorometric determination of Daclatasvir in its tablet and spiked human plasma.
Abou El-Alamin, MM; Azab, MM; Sultan, MA; Wark, AW, 2019
)
0.51
" To achieve once a day dosage form with enhanced solubility and controlled release, double controlled release CIL matrix tablets (DCRT) were designed by modulating a sol-gel process of binary polymeric blends of a pH-independent hydroxylpropylmethylcellulose (HPMC) and a pH-dependent polymer (carbomer) assisted with anionic surfactant (sodium lauryl sulfate, SLS)."( Double controlled release of highly insoluble cilostazol using surfactant-driven pH dependent and pH-independent polymeric blends and in vivo bioavailability in beagle dogs.
Cho, SM; Choi, YW; Lee, BJ; Meghani, NM; Nam, KY; Park, C; Park, JB, 2019
)
0.51
"This study investigates the influence of surfactant sodium lauryl sulfate (SLS) on the solubility of poorly-water soluble drug substances, model Compound X and Compound Y, used in a fixed dose combination oral solid dosage form."( Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling.
Bahr, MN; Campbell, G; Modi, D; Patel, S; Stockdale, G, 2019
)
0.51
", by inclusion in the dosing vehicle), only a limited degree of nanoparticle formation was observed even at the optimized surfactant-to-drug ratios."( Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions.
Chen, JZ; Chiang, PC; Estevez, A; Hau, J; Hu, C; Kuhn, R; Leung, DH; Nagapudi, K; Yen, CW; Zhang, W, 2021
)
0.62
" Despite these excipients are always required for the tablets production, their amount must be carefully evaluated since lubricants can negatively impact on mechanical strength, disintegration and dissolution behavior of solid dosage forms."( Sodium lauryl sulfate as lubricant in tablets formulations: Is it worth?
Bonacucina, G; Cespi, M; Filippo Palmieri, G; Romano Perinelli, D; Sabbatini, B, 2023
)
0.91
" The enhanced fluorescence was employed as a basis for the development of a novel microwell spectrofluorimetric assay (MW-SFA) for the determination of LOR in its pharmaceutical dosage forms and urine samples."( Dual fluorescence enhancement of loratidine by photoinduced electron transfer blocking and micellization: Application to the development of novel highly sensitive microwell spectrofluorimetric assay for analysis of dosage forms and urine samples.
Alzoman, NZ; Darwish, IA, 2024
)
1.44
" Optimization of the preparation process considered factors like molar Mg/Fe ratio, CKD dosage, pH, and SDS dosage using Response Surface Methodology (RSM)."( Preparation of coated MgFe layered double hydroxide nanoparticles on cement kiln dust and intercalated with sodium dodecyl sulfate as an intermediate layer for the adsorption of estrogen from water.
Abdul-Kareem, MB; Al-Ansari, N; Faisal, AAH; Hassan, WH; Hatshan, MR; Lakhera, SK; Rashid, HM, 2023
)
1.12
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (69 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care18
Household Essentials48
Baby & Kids Products1
Vitamins & Supplements2

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Attitude Attitude Toothpaste Fluoride Whitening Peppermint -- 4.05 ozAttitudeBeauty & Personal Carecitric acid, citric acid, glycerin, sodium benzoate, sodium lauryl sulfate, titanium dioxide2024-11-29 10:47:42
Attitude Toothpaste Fluoride Complete Protection Spearmint -- 4.05 ozAttitudeBeauty & Personal Carecitric acid, citric acid, wintergreen, sodium benzoate, sodium bicarbonate, sodium lauryl sulfate, titanium dioxide2024-11-29 10:47:42
Auromere Ayurvedic Herbal Toothpaste Mint Free Unflavored -- 4 ozAuromereBeauty & Personal Careanethol, catechu, cellulose, glycerine, p thymol, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Dish Liquid Citrus and Aloe -- 25 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, decyl glucoside, lauramine oxide, glycerin, limonene, phenoxyethanol, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Dish Liquid Free & Clear -- 25 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Dish Liquid Lavender Lily -- 25 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, decyl glucoside, lauramine oxide, glycerin, linalool, phenoxyethanol, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Laundry Liquid 128 Loads Citrus Essence -- 64 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, lauramine oxide, glycerin, limonene, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Laundry Liquid 128 Loads Lavender Lily -- 64 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, lauramine oxide, glycerin, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Laundry Liquid Free & Clear 128 Loads Fragrance Free -- 64 fl ozBiokleenHousehold Essentialscocamidopropyl betaine, lauramine oxide, glycerin, phenoxyethanol, sodium lauryl sulfate2024-11-29 10:47:42
Biokleen Sport Laundry Liquid HE Lavender & Eucalyptus -- 64 fl oz - 128 LoadsBiokleenHousehold Essentialscocamidopropyl betaine, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Common Ground Natural Body Wash With Avocado -- 16.9 fl ozCommon GroundBeauty & Personal Carecitric acid, citric acid, cocamidopropyl betaine, diethyl phthalate, galaxolide, glycerine, methyl dihydrojasmonate, sodium benzoate, sodium lauryl ether sulfate2024-11-29 10:47:42
Common Ground Natural Shampoo & Conditioner Set -- 16.9 fl oz Each / 2 PackCommon GroundBeauty & Personal Carecitric acid, citric acid, cocamidopropyl betaine, glycerine, sodium benzoate, sodium lauryl ether sulfate2024-11-29 10:47:42
ECOS Laundry Detergent Sheets HE Free & Clear -- 50 LoadsECOSHousehold Essentialscitric acid, saponins, citric acid, cocamidopropyl betaine, glycerin, dimethicone, Kaolin, phenoxyethanol, propylene glycol, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
ECOS Laundry Detergent Sheets HE Lavender Vanilla -- 50 LoadsECOSHousehold Essentialscitric acid, saponins, citric acid, cocamidopropyl betaine, coumarin, coumarin, triethyl citrate, glycerin, dimethicone, Kaolin, linalool, phenoxyethanol, propylene glycol, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
ECOS Laundry Detergent Sheets HE Magnolia & Lily -- 50 LoadsECOSHousehold Essentialscitric acid, benzyl salicylate, saponins, citric acid, cocamidopropyl betaine, coumarin, coumarin, glycerin, dimethicone, hexyl cinnamal, Kaolin, phenoxyethanol, propylene glycol, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
EcoSmart Mosquito & Tick Control -- 32 fl ozEcoSmartHousehold EssentialsSodium Lauryl Sulfate2024-11-29 10:47:42
Ecover Dish Soap Lime Zest -- 25 fl ozEcoverHousehold Essentialscitric acid, citric acid, glycerin, limonene, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Ecover Dish Soap Pink Geranium -- 25 ozEcoverHousehold Essentialscitric acid, citric acid, glycerin, linalool, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Ecover Dish Soap Zero Fragrance Free -- 25 fl ozEcoverHousehold Essentialsglycerin, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Ecover Liquid Laundry Detergent HE Fragrance Free -- 93 fl oz - 62 LoadsEcoverHousehold Essentialscitric acid, citric acid, decyl glucoside, glycerin, laureth-6, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Euthymol Original Toothpaste -- 3.7 ozEuthymolBeauty & Personal Caretocopherol acetate, Dicalcium phosphate, red 33, glycerin, sodium lauryl sulfate, sorbitol, titanium dioxide2024-11-29 10:47:42
GrabGreen Delicate Laundry Detergent Pods Fragrance-Free -- 60 LoadsGrabGreenHousehold Essentialscitric acid, citric acid, sodium bicarbonate, sodium citrate, sodium lauryl ether sulfate2024-11-29 10:47:42
Hobe Labs Energizer Treatment Shampoo -- 4 fl ozHobe LabsBeauty & Personal CareChamomile, Comfrey, DL-Panthenol, vitamin B-5, Phenoxyethanol, Sodium Lauroyl Sarcosinate, Sodium Lauryl Sulfate2024-11-29 10:47:42
Lemi Shine Garbage Disposal Cleaner Fresh Lemon -- 2 PodsLemi ShineHousehold Essentialsd-limonene, isopropyl alcohol, citric acid, citral, citric acid, geraniol, linalool, sodium bicarbonate, sodium carbonate, sodium lauryl sulfate2024-11-29 10:47:42
Lemi Shine Glass + Surface Cleaner Spray with GunkGuard -- 28 fl ozLemi ShineHousehold Essentialssodium citrate, sodium lauryl ether sulfate2024-11-29 10:47:42
Licefreee Shampoo Gel Comb Kit -- 1 KitLicefreeeBaby & Kids Productscarbomer, cocamidopropyl betaine, sodium lauryl sulfate2024-11-29 10:47:42
Life Extension Low Dose Aspirin -- 81 mg - 300 Enteric Coated TabsLife ExtensionVitamins & Supplementstriethyl citrate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac, sodium bicarbonate, sodium lauryl sulfate, sodium hydroxide, titanium dioxide2024-11-29 10:47:42
Method Dish Soap Refill Clementine -- 54 fl ozMethodHousehold Essentialsmethylisothiazolinone, citric acid, methylchloroisothiazolinone, citric acid, decyl glucoside, lauramine oxide, glycerin, limonene, linalool, sodium lauryl sulfate2024-11-29 10:47:42
Method Foaming Hand Wash Lemon Mint -- 10 fl ozMethodHousehold Essentialsmethylisothiazolinone, citric acid, methylchloroisothiazolinone, citric acid, cocamidopropyl betaine, vitamin E, vitamin E, glycerin, limonene, sodium citrate, sodium lauryl sulfate, benzophenone-4, yellow 52024-11-29 10:47:42
Method Foaming Hand Wash Sea Minerals -- 10 fl ozMethodHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, glycerin, sodium citrate, sodium lauryl sulfate, benzophenone-42024-11-29 10:47:42
Method Gel Hand Wash Pink Grapefruit -- 12 fl ozMethodHousehold Essentialsmethylisothiazolinone, citric acid, methylchloroisothiazolinone, citric acid, cocamidopropyl betaine, vitamin E, red 33, vitamin E, glycerin, sodium citrate, sodium lauryl sulfate, benzophenone-42024-11-29 10:47:42
Method Gel Hand Wash Refill - Vanilla + Raspberry -- 34 fl ozMethodHousehold Essentialscitric acid, citric acid, cocamidopropyl betaine, glycerin, sodium benzoate, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Method Gel Hand Wash Sweet Water -- 12 fl ozMethodHousehold Essentialscitric acid, methylchloroisothiazolinone, tocopherol acetate, citric acid, cocamidopropyl betaine, glycerin, sodium citrate, sodium lauryl sulfate, benzophenone-42024-11-29 10:47:42
Perioe Himalaya Pink Salt Toothpaste Ice Mint -- 3.4 ozPerioeBeauty & Personal Careglycerin, microcrystalline cellulose, mannitol, menthol, sodium lauryl sulfate, tetrasodium pyrophosphate, sorbitol, titanium dioxide2024-11-29 10:47:42
Perioe Himilaya Pink Salt Toothpaste Charcoal -- 3.4 ozPerioeBeauty & Personal Carecellulose, glycerin, mannitol, menthol, methylcellulose, sodium benzoate, sodium lauryl sulfate, tetrasodium pyrophosphate, sorbitol, titanium dioxide2024-11-29 10:47:42
Perioe POP Prebiotic Microbiome Sensitive Care Toothpaste Clean Mint -- 4.2 ozPerioeBeauty & Personal Caresodium gluconate, sodium lauryl sulfate, sodium hydroxide, sorbitol, titanium dioxide, sucralose, xylitol2024-11-29 10:47:42
Perioe POP Prebiotic Microbiome Total Care Toothpaste Fresh Mint -- 4.2 ozPerioeBeauty & Personal Carebutylene glycol, arginine, glycerin, sodium lauryl sulfate, tetrasodium pyrophosphate, sorbitol, titanium dioxide, xylitol2024-11-29 10:47:42
Perioe POP Prebiotic Microbiome Whitening Toothpaste Cool Mint -- 4.2 ozPerioeBeauty & Personal Carecocamidopropyl Betaine, trisodium phosphate, peg-6, sodium lauryl sulfate, titanium dioxide, sucralose2024-11-29 10:47:42
SECURE Cleansing Tablets -- 32 TabletsSECUREBeauty & Personal CarePVP, trisodium phosphate, potassium monopersulphate, Sodium lauryl sulphate, sodium carbonate peroxyhydrate, sulfamic acid2024-11-29 10:47:42
Seventh Generation Concentrated Liquid Laundry Detergent 66 Loads Free & Clear -- 50 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, glycerin, laureth-6, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Chamomile and Lemon -- 19 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, chamomile, citric acid, decyl glucoside, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Clementine Zest Lemongrass -- 19 fl ozSeventh GenerationHousehold Essentialsd-limonene, orange, citric acid, citric acid, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Fragrance Free -- 19 fl ozSeventh GenerationHousehold Essentialscitric acid, citric acid, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Fresh Lime & Ginger -- 19 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, orange, geranium, citric acid, citric acid, decyl glucoside, lauramine oxide, glycerin, nutmeg, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Lavender Flower & Mint -- 19 fl ozSeventh GenerationHousehold Essentialsorange, citric acid, citric acid, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap - Summer Orchard -- 19 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, gamma-decalactone, decyl glucoside, lauramine oxide, glycerin, isoamyl acetate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap Refill - Clementine Zest & Lemongrass -- 50 fl ozSeventh GenerationHousehold Essentialsorange, citric acid, citric acid, decyl glucoside, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap Refill - Fragrance Free -- 50 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, decyl glucoside, lauramine oxide, glycerin, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap Refill - Lavender Flower & Mint -- 50 fl ozSeventh GenerationHousehold Essentialscitric acid, citric acid, lauramine oxide, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Dish Liquid Soap Rejuvenate - Yuzu Basil with Phytogaia -- 19 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, orange, citric acid, citral, citric acid, citronellol, decyl glucoside, lauramine oxide, eucalyptol, glycerin, linalool, raspberry ketone, sodium lauryl sulfate, gamma-undecalactone2024-11-29 10:47:42
Seventh Generation Disinfectant Wipes Lemongrass Citrus -- 35 WipesSeventh GenerationHousehold Essentialscitric acid, citric acid, bluestone, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Liquid Laundry Detergent 60 Loads Fragrance Free -- 90 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, glycerin, laureth-6, sodium oleate, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Liquid Laundry Detergent 60 Loads Fresh Lavender -- 90 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, citronellol, glycerin, laureth-6, sodium oleate, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Liquid Laundry Detergent 90 Loads Fragrance Free -- 135 fl ozSeventh GenerationHousehold Essentialsmethylisothiazolinone, citric acid, citric acid, laureth-6, sodium citrate, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Multi Surface Wipes - Lemon Zest -- 70 WipesSeventh GenerationHousehold Essentialscitronella, citronellol, geraniol, sodium lauryl sulfate2024-11-29 10:47:42
Seventh Generation Multi-Surface Disinfecting Cleaner Spray Lemongrass Citrus -- 26 fl ozSeventh GenerationHousehold Essentialssodium lauryl sulfate, thymol2024-11-29 10:47:42
Slow Mag Mg Muscle + Heart Magnesium Chloride + Calcium -- 60 TabletsSlow MagVitamins & SupplementsChloride, microcrystalline cellulose, calcium carbonate, maltodextrin, sodium lauryl sulfate, stearic acid, titanium dioxide, triacetin2024-11-29 10:47:42
SoapBox Liquid Hand Soap Deep Moisture - Coconut Milk & Sandalwood -- 12 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
SoapBox Liquid Hand Soap Deep Moisture Refill Coconut Milk & Sandalwood -- 64 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
SoapBox Liquid Hand Soap Gentle Moisture Sea Minerals & Blue Iris -- 12 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
SoapBox Liquid Hand Soap Nourishing Moisture Refill Vanilla & Lily Blossom -- 64 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
SoapBox Liquid Hand Soap Nourishing Moisture Vanilla & Lilly Blossom -- 12 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
SoapBox Liquid Hand Soap Reviving Moisture - Citrus & Peach Rose -- 12 fl ozSoapBoxHousehold Essentialsbenzyl alcohol, cocamidopropyl betaine, dehydroacetic acid, sodium laureth sulfate, glycerin, sodium lauryl sulfate2024-11-29 10:47:42
The Unscented Company Floor Cleaner Tabs Unscented -- 22 TabsThe Unscented CompanyHousehold Essentialscitric acid, citric acid, sodium bicarbonate, sodium citrate, sodium lauryl sulfate, sodium sulfate2024-11-29 10:47:42
Vitabath Bubble Bath Black Plum -- 33.8 fl ozVitabathBeauty & Personal CareDMDM hydantoin, citric acid, ascorbic acid, citric acid, cocamidopropyl betaine, panthenol, sodium laureth sulfate, glycerin, niacinamide, retinyl palmitate, sodium lauryl sulfate2024-11-29 10:47:42
Vitabath Bubble Bath Cucumber & White Tea -- 33.8 fl ozVitabathBeauty & Personal Carecitric acid, ascorbic acid, citric acid, cocamidopropyl betaine, panthenol, sodium laureth sulfate, glycerin, niacinamide, retinyl palmitate, sodium lauryl sulfate2024-11-29 10:47:42
Vitabath Bubble Bath Heavenly Coconut Creme -- 33.8 fl ozVitabathBeauty & Personal Carecitric acid, ascorbic acid, citric acid, cocamidopropyl betaine, panthenol, sodium laureth sulfate, glycerin, niacinamide, retinyl palmitate, sodium lauryl sulfate2024-11-29 10:47:42
Vitabath Bubble Bath Lavender & Chamomile -- 33.8 fl ozVitabathBeauty & Personal Carecitric acid, ascorbic acid, citric acid, cocamidopropyl betaine, panthenol, sodium laureth sulfate, glycerin, niacinamide, retinyl palmitate, sodium lauryl sulfate2024-11-29 10:47:42
Vitabath Bubble Bath Pomegranate Bellini Blush™ -- 33.8 fl ozVitabathBeauty & Personal Carecitric acid, ascorbic acid, citric acid, cocamidopropyl betaine, panthenol, sodium laureth sulfate, glycerin, niacinamide, retinyl palmitate, sodium lauryl sulfate2024-11-29 10:47:42

Roles (2)

RoleDescription
detergentA surfactant (or a mixture containing one or more surfactants) having cleaning properties in dilute solutions.
protein denaturantnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
organic sodium salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
betacyanin biosynthesis124

Protein Targets (40)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency39.81070.125919.1169125.8920AID2549
Chain A, CruzipainTrypanosoma cruziPotency28.37090.002014.677939.8107AID1476
LuciferasePhotinus pyralis (common eastern firefly)Potency69.89190.007215.758889.3584AID1224835; AID624030
interleukin 8Homo sapiens (human)Potency74.97800.047349.480674.9780AID651758
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency24.23053.189029.884159.4836AID1224846
RAR-related orphan receptor gammaMus musculus (house mouse)Potency14.96010.006038.004119,952.5996AID1159521
SMAD family member 2Homo sapiens (human)Potency24.19040.173734.304761.8120AID1346859
USP1 protein, partialHomo sapiens (human)Potency79.43280.031637.5844354.8130AID504865
SMAD family member 3Homo sapiens (human)Potency24.19040.173734.304761.8120AID1346859
GLI family zinc finger 3Homo sapiens (human)Potency41.77860.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency27.30600.000221.22318,912.5098AID743040
thyroid stimulating hormone receptorHomo sapiens (human)Potency39.81070.001318.074339.8107AID926; AID938
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency26.91770.003041.611522,387.1992AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency61.64480.000817.505159.3239AID1159527
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency40.31280.001530.607315,848.9004AID1224849; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency27.07930.375827.485161.6524AID588527; AID743220
pregnane X nuclear receptorHomo sapiens (human)Potency60.26130.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency30.72020.000229.305416,493.5996AID743069; AID743075; AID743078
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency53.08220.001024.504861.6448AID743212; AID743227
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency39.81070.001019.414170.9645AID588537
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency22.49580.023723.228263.5986AID743222; AID743223; AID743241
alpha-galactosidaseHomo sapiens (human)Potency39.81074.466818.391635.4813AID2107
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency0.01220.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency67.61430.001628.015177.1139AID1224843; AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency54.955519.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency54.94100.057821.109761.2679AID1159526; AID1159528
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1Homo sapiens (human)Potency11.22020.001815.663839.8107AID894
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency44.66840.354828.065989.1251AID504847
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency28.12020.010039.53711,122.0200AID588547
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency34.53160.000323.4451159.6830AID743065; AID743067
mitogen-activated protein kinase 1Homo sapiens (human)Potency39.81070.039816.784239.8107AID995
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency72.40490.000627.21521,122.0200AID651741; AID743202; AID743219
gemininHomo sapiens (human)Potency9.44110.004611.374133.4983AID624297
histone acetyltransferase KAT2A isoform 1Homo sapiens (human)Potency35.48130.251215.843239.8107AID504327
lethal factor (plasmid)Bacillus anthracis str. A2012Potency0.10000.020010.786931.6228AID912
lamin isoform A-delta10Homo sapiens (human)Potency0.00090.891312.067628.1838AID1487
Cellular tumor antigen p53Homo sapiens (human)Potency44.04220.002319.595674.0614AID651631; AID720552
Spike glycoproteinSevere acute respiratory syndrome-related coronavirusPotency6.30960.009610.525035.4813AID1479145
Peroxisome proliferator-activated receptor alphaHomo sapiens (human)Potency44.66840.015823.527344.6684AID651778
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bifunctional epoxide hydrolase 2Homo sapiens (human)IC50 (µMol)135.50000.00000.54509.1000AID1615721; AID1615722; AID1615730
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (177)

Processvia Protein(s)Taxonomy
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
response to toxic substanceBifunctional epoxide hydrolase 2Homo sapiens (human)
positive regulation of gene expressionBifunctional epoxide hydrolase 2Homo sapiens (human)
dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
cholesterol homeostasisBifunctional epoxide hydrolase 2Homo sapiens (human)
stilbene catabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
phospholipid dephosphorylationBifunctional epoxide hydrolase 2Homo sapiens (human)
regulation of cholesterol metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide metabolic processBifunctional epoxide hydrolase 2Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of reactive oxygen species biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of hepatocyte apoptotic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of signaling receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of ATP biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transformation of host cell by virusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to hypoxiaPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
heart developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to nutrientPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
epidermis developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to starvationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of cellular ketone metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cholesterol storagePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of sequestering of triglyceridePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
intracellular receptor signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid beta-oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of appetitePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to insulinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
circadian regulation of gene expressionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
behavioral response to nicotinePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
wound healingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipoprotein metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of circadian rhythmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
steroid hormone mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
response to ethanolPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of gluconeogenesisPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of blood pressurePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of glycolytic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nitric oxide metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid oxidationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of inflammatory responsePeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of cell growth involved in cardiac muscle cell developmentPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
enamel mineralizationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cellular response to fructose stimulusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of miRNA transcriptionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
negative regulation of leukocyte cell-cell adhesionPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
regulation of fatty acid transportPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
hormone-mediated signaling pathwayPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
positive regulation of fatty acid metabolic processPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
cell differentiationPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (55)

Processvia Protein(s)Taxonomy
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
magnesium ion bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
epoxide hydrolase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
toxic substance bindingBifunctional epoxide hydrolase 2Homo sapiens (human)
phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lipid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
protein homodimerization activityBifunctional epoxide hydrolase 2Homo sapiens (human)
lysophosphatidic acid phosphatase activityBifunctional epoxide hydrolase 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
transcription coactivator bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear steroid receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nuclear receptor activityPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
zinc ion bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
lipid bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
phosphatase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein domain specific bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
mitogen-activated protein kinase kinase kinase bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
ubiquitin conjugating enzyme bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
sequence-specific DNA bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
protein-containing complex bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
NFAT protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
MDM2/MDM4 family protein bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
DNA-binding transcription factor bindingPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (23)

Processvia Protein(s)Taxonomy
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomal matrixBifunctional epoxide hydrolase 2Homo sapiens (human)
cytosolBifunctional epoxide hydrolase 2Homo sapiens (human)
extracellular exosomeBifunctional epoxide hydrolase 2Homo sapiens (human)
peroxisomeBifunctional epoxide hydrolase 2Homo sapiens (human)
virion membraneSpike glycoproteinSevere acute respiratory syndrome-related coronavirus
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleoplasmPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
chromatinPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
nucleusPeroxisome proliferator-activated receptor alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (119)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347424RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347425Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)2019The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1615730Inhibition of hexa-His-tagged human soluble epoxide hydrolase C-terminal hydrolase domain expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before DiFMUP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID571885Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID613556Antibacterial activity against 5 x 10'5 CFU/mL Enterococcus faecalis ATCC 29212 incubated for 72 hrs followed by growing of cells on trypticase soy agar plate for 24 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID368422Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID531322Antifungal activity against Candida parapsilosis 5986 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID1513897Disruption of inner membrane integrity in Escherichia coli MG1655 assessed as induction of OPNG conversion at 256 ug/ml measured at 10 mins intervals for 1 hr2018Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.
AID1615721Inhibition of hydrolase activity of full length human soluble epoxide hydrolase pre-incubated for 30 mins before PHOME substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID637042Antimycobacterial activity against Mycobacterium tuberculosis H37Rv expressing pSMT1 after 1 to 7 days by luminescent assay2012European journal of medicinal chemistry, Feb, Volume: 48Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
AID1660345Biosurfactant activity assessed as diameter of clear zone at 10 mg/ml by oil displacement assay2020Journal of natural products, 06-26, Volume: 83, Issue:6
Biosurfactants from Marine Cyanobacteria Collected in Sabah, Malaysia.
AID1615722Inhibition of phosphatase activity of full length human soluble epoxide hydrolase pre-incubated for 30 mins before FDP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID637045Selectivity index, ratio of IC50 for human HepG2/C3A cells to MIC50 for Mycobacterium tuberculosis H37Rv2012European journal of medicinal chemistry, Feb, Volume: 48Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
AID181151Percent Hemolysis observed in rat red blood cells when Treated with 5 mM concentration2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
AID613553Antibacterial activity against 5 x 10'5 CFU/mL Enterococcus faecalis ATCC 29212 after 72 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID571884Antibacterial activity against Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID181150Percent Hemolysis observed in rat red blood cells when Treated with 2 mM concentration2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
AID531531Antifungal activity against Candida albicans DAY 185 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID1513898Disruption of inner membrane integrity in Pseudomonas aeruginosa PAO1 ATCC 15692 co-expressing pMP2200::PrrnB plasmid assessed as induction of OPNG conversion at 256 ug/ml measured at 10 mins intervals for 1 hr2018Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.
AID531532Antifungal activity against Candida albicans K1 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID421183Displacement of C18-Aib-lucifer yellow from HIV1 envelope glycoprotein gp41 Fe(env2.0)3 receptor by fluorescence assay2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.
AID531323Antifungal activity against Candida glabrata 5740 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID396282Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP2 plasmid containing Enterobacter cloacae acrA gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID1615708Inhibition of hexa-His-tagged human soluble epoxide hydrolase N-terminal phosphatase domain expressed in Escherichia coli BL21(DE3) pre-incubated for 30 mins before FDP substrate addition by fluorescence based assay2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID1203476Induction of bacterial cell lysis in methicillin-resistant Staphylococcus aureus assessed as cell recovery at 2% by time kill assay2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
Combinatorial Libraries As a Tool for the Discovery of Novel, Broad-Spectrum Antibacterial Agents Targeting the ESKAPE Pathogens.
AID404163Effect on morphological changes in reconstituted human epidermis model assessed as induction of tissue degeneration and necrosis after 24 hrs2005Journal of natural products, Nov, Volume: 68, Issue:11
Anti-inflammatory activity of verminoside from Kigelia africana and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis.
AID288195Toxicity assessed as induction of haemolysis in rat erythrocytes at 50 mM after 30 mins2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery.
AID368421Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID181149Percent Hemolysis observed in rat red blood cells when Treated with 1 mM concentration2003Journal of medicinal chemistry, Mar-27, Volume: 46, Issue:7
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII.
AID531533Antifungal activity against Candida parapsilosis 5986 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID523105Antimicrobial activity against Proteus mirabilis dU2 knockout mutant transformed with pACYC184-ugd after 16 to 18 hrs by broth micro dilution assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
AID396284Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pAP3 plasmid containing Enterobacter aerogenes acrR gene by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID368423Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID571883Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method in presence of 25 ug/ml efflux pump inhibitor CCCP2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID531327Antifungal activity against Candida parapsilosis 5986 grown as planktonic cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID531319Antifungal activity against Candida albicans DAY 185 assessed as inhibition of biofilm formation after 24 hrs by XTT reduction assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID584116Ratio of MIC for Escherichia coli KAM32 harboring cloned pSP72 lmrS to MIC for Escherichia coli KAM32 harboring pSP722010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID584114Antibacterial activity against Escherichia coli KAM32 harboring Staphylococcus aureus cloned pSP72 lmrS by broth microdilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID531326Antifungal activity against Candida albicans K1 grown as planktonic cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID283562Effect on modulation in uptake of [3H]hydrocortisone in Escherichia coli AG102 with marR1 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID637044Cytotoxicity against human HepG2/C3A cells after 24 hrs by neutral red uptake assay2012European journal of medicinal chemistry, Feb, Volume: 48Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents.
AID572062Antibacterial activity against abeS sigma abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID531320Antifungal activity against Candida albicans DAY 185 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID1660343Biosurfactant activity assessed as Critical micelle concentration of compound2020Journal of natural products, 06-26, Volume: 83, Issue:6
Biosurfactants from Marine Cyanobacteria Collected in Sabah, Malaysia.
AID572061Ratio of MIC for Acinetobacter baumannii AC0037 to MIC for abeS-deficient Acinetobacter baumannii AC00372009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID613551Antibacterial activity against 5 x 10'5 CFU/mL Pseudomonas aeruginosa Boston 41501 ATCC 27853 after 72 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID572060Antibacterial activity against abeS-deficient Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID531328Antifungal activity against Candida glabrata 5740 grown as planktonic cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID396281Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pBGS18 plasmid by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID283558Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID283560Antibacterial activity against Escherichia coli HNCE4 after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID613559Antibacterial activity against 5 x 10'5 CFU/mL Escherichia coli ATCC 25922 incubated for 72 hrs followed by growing of cells on trypticase soy agar plate for 24 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID531324FICI in Candida albicans DAY 185 after 24 hrs in presence of fluconazole2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID404162Antiinflammatory activity against reconstituted human epidermis model assessed as inhibition of IL1alpha release after 72 hrs by ELISA relative to control2005Journal of natural products, Nov, Volume: 68, Issue:11
Anti-inflammatory activity of verminoside from Kigelia africana and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis.
AID368419Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID368418Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1513899Disruption of inner membrane integrity in Acinetobacter baumannii ATCC 19606 co-expressing pMP2200::PrrnB plasmid assessed as induction of OPNG conversion at 256 ug/ml measured at 10 mins intervals for 1 hr2018Journal of medicinal chemistry, 10-25, Volume: 61, Issue:20
Alkyl-guanidine Compounds as Potent Broad-Spectrum Antibacterial Agents: Chemical Library Extension and Biological Characterization.
AID531534Antifungal activity against Candida glabrata 5740 grown as planktonic cells using 10'6 to 10'7 cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID396283Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate expressing pACYC184 plasmid by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID396042Antibacterial activity against drug-resistant Enterobacter cloacae EcDC64 isolate expressing AcrAB-TolC efflux pump by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID523104Antimicrobial activity against Proteus mirabilis dG1 knockout after 16 to 18 hrs by broth micro dilution assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
AID283563Effect on modulation in uptake of [3H]testosterone in Escherichia coli AG102 with marR1 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1203480Bactericidal activity against methicillin-resistant Staphylococcus aureus assessed as cell survival recovery at 2% measured after drug wash out after 120 mins by time kill assay2015Journal of medicinal chemistry, Apr-23, Volume: 58, Issue:8
Combinatorial Libraries As a Tool for the Discovery of Novel, Broad-Spectrum Antibacterial Agents Targeting the ESKAPE Pathogens.
AID523106Antimicrobial activity against Proteus mirabilis dG1 knockout mutant transformed with pACYC184-galU after 16 to 18 hrs by broth micro dilution assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
AID288196Toxicity assessed as induction of haemolysis in rat erythrocytes at 200 mM after 30 mins2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery.
AID531321Antifungal activity against Candida albicans K1 assessed as decrease mature biofilm burden after 24 hrs by XTT reduction assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID396280Antibacterial activity against drug-resistant AcrAB-TolC efflux pump deficient Enterobacter cloacae EcdeltaacrA isolate by broth microdilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
Cloning, nucleotide sequencing, and analysis of the AcrAB-TolC efflux pump of Enterobacter cloacae and determination of its involvement in antibiotic resistance in a clinical isolate.
AID523102Antimicrobial activity against wild type Proteus mirabilis N2 after 16 to 18 hrs by broth micro dilution assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
AID421186Critical micellar concentration of the compound2009Journal of medicinal chemistry, Jul-23, Volume: 52, Issue:14
The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.
AID288197Toxicity assessed as induction of haemolysis in rat erythrocytes at 1000 mM after 30 mins2007Bioorganic & medicinal chemistry, Jun-15, Volume: 15, Issue:12
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery.
AID283561Effect on modulation in uptake of [3H]progesterone in Escherichia coli AG102 with marR1 mutation2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1309142Inhibition of human Akt1 PH domain using AKTide-2T as substrate at 100 uM by ELISA2016Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16
Synthetic sulfoglycolipids targeting the serine-threonine protein kinase Akt.
AID572059Antibacterial activity against Acinetobacter baumannii AC0037 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID404161Antiinflammatory activity against reconstituted human epidermis model assessed as inhibition of IL1alpha release after 24 hrs by ELISA relative to control2005Journal of natural products, Nov, Volume: 68, Issue:11
Anti-inflammatory activity of verminoside from Kigelia africana and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis.
AID613560Antibacterial activity against 5 x 10'5 CFU/mL Pseudomonas aeruginosa Boston 41501 ATCC 27853 incubated for 72 hrs followed by growing of cells on trypticase soy agar plate for 24 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID283559Antibacterial activity against Escherichia coli AG102MB after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1615729Induction of stabilization of hexa-His-tagged human soluble epoxide hydrolase N-terminal phosphatase domain expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 50 uM by differential scanning fluorimetry2019Journal of medicinal chemistry, 09-26, Volume: 62, Issue:18
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
AID613558Antibacterial activity against 5 x 10'5 CFU/mL Staphylococcus aureus subsp. aureus ATCC 29213 incubated for 72 hrs followed by growing of cells on trypticase soy agar plate for 24 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID613554Antibacterial activity against 5 x 10'5 CFU/mL Staphylococcus aureus subsp. aureus ATCC 29213 after 72 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID584115Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID523103Antimicrobial activity against Proteus mirabilis dU2 knockout mutant after 16 to 18 hrs by broth micro dilution assay2010Antimicrobial agents and chemotherapy, May, Volume: 54, Issue:5
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence.
AID572058Ratio of MIC for Escherichia coli KAM32 harboring plasmid pUC18 to MIC for Escherichia coli KAM32 harboring recombinant plasmid pVBS1 encoding Acinetobacter baumannii abeS gene2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID368424Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID368420Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID531325Antifungal activity against Candida albicans DAY 185 grown as planktonic cells by CLSI method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Reduced biocide susceptibility in Candida albicans biofilms.
AID613552Antibacterial activity against 5 x 10'5 CFU/mL Escherichia coli ATCC 25922 after 72 hrs by CLSI M07-A8 broth microdilution method2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
Bicephalic amphiphile architecture affects antibacterial activity.
AID571882Antibacterial activity against Escherichia coli KAM32 harboring plasmid pUC18 by CLSI broth microdilution method2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12,507)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905189 (41.49)18.7374
1990's2118 (16.93)18.2507
2000's2468 (19.73)29.6817
2010's2264 (18.10)24.3611
2020's468 (3.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 106.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index106.55 (24.57)
Research Supply Index9.49 (2.92)
Research Growth Index4.44 (4.65)
Search Engine Demand Index202.31 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (106.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials257 (1.99%)5.53%
Reviews136 (1.05%)6.00%
Case Studies47 (0.36%)4.05%
Observational2 (0.02%)0.25%
Other12,504 (96.59%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]